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This dissertation presents a state-of-the-art research of 1,2-cis-glycosides, 
including synthetic methodology development, combinatorial total synthesis of 
galactoside ligands, construction of glycomicroarray surfaces, and quantitative evaluation 
of carbohydrate–lectin binding properties. 
In Chapter 1, as a general introduction, various strategies that have been 
developed for the stereoselective construction of 1,2-cis-O-glycosidic bond are reviewed. 
1,2-cis-O-Glycoside structural units are ubiquitous in nature, and they are extensively 
involved in numerous biological activities. The systematic identification and evaluation 
of the roles of carbohydrates usually relies on practical synthetic approaches to afford 
pure carbohydrates in considerable quantities. Further development of general and 
efficient approaches to achieve the intrinsic organizational diversity of carbohydrates is 
still urged in order to meet the substantial carbohydrates in demand for biological, 
medicinal, and therapeutic studies. 
In Chapter 2, I report a 1,2-cis-glycosidation protocol that makes use of 
unprotected phenyl 1-thioglycosyl donors. Glycosylation of various functionalized 
alcohols was accomplished in moderate to high yield and selectivity to give the 1,2-cis-
glycosides. In order to quickly optimize glycosylation conditions, a flow injection 
analysis method was established that enabled rapid and quantitative evaluation of yield 
on small scale. This methodology, together with nuclear magnetic resonance 
spectroscopy, allowed for rapid evaluation of the overall reactions. 
In Chapter 3, I describe the synthesis of alpha-linked propargyl terminated 




construction of synthetic carbohydrate microarrays to mimic featured carbohydrate 
presentations on a cell surface. Through the routes, glycosyl acceptors were obtained via 
flexible and efficient regioselective protection strategies, and they were glycosylated with 
an alpha-directing glycosyl donor to have the alpha-linked galactosides in exclusive 
stereoselective and satisfactory yield.  
In Chapter 4, the establishment of a synthetic carbohydrate microarray is 
described. The carbohydrate surface was interrogated by a fluorescence-labeled lectin to 
quantitatively analyze the carbohydrate-binding affinities and dissociation constants. This 
study will add new dimensions to our understanding of the effects of spatial arrangement 
of carbohydrate ligands in carbohydrate–lectin binding, and shed light on elucidating the 
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Oligosaccharides and glycoconjugates containing 1,2-cis-glycoside structural 
units are ubiquitous in nature with numerous biological roles. An increasing 
understanding of the biological roles has led to a significant demand for these 
carbohydrates for biological, medicinal, and therapeutic studies. Therefore, considerable 
effort has been devoted to develop efficient and general strategies for the synthesis of 
glycosides with 1,2-cis-stereocontrol. The scope of this overview is on the recent 
advances that have been developed to address the challenge of stereoselective 1,2-cis-O-
glycosylation. Glycosyl donors with diverse leaving groups, protecting groups, and their 
corresponding activation conditions are presented, and the subtle influences of these 

















As one of the essential components in living systems, carbohydrates, including 
natural glycosides, oligosaccharides, polysaccharides and glycocalyx, are ubiquitous in 
nature. Tons of carbohydrates are produced by plants and microorganisms on a yearly 
basis through the photosynthesis process. Cellulose, which is a structural polysaccharide 
with β-1,4-linkage, is the most abundant chemical substance on the planet. Carbohydrates 
perform numerous biological roles and sustain the metabolism in living systems. In the 
past, the functionalities ascribed to carbohydrates were limited to energy storage and 
skeletal components. However, with the first isolation and identification of a 
carbohydrate-binding protein, their diverse roles in biological systems sparked great 
interest and a multitude of efforts, which resulted in the emerging of ‘Glycobiology’ as a 
science. Nowadays, people realize that carbohydrates are heavily involved in the cellcell 
recognition and cellexternal agent interactions. Since cell membranes are covered with a 
thick layer of glycoconjugates, they form the basis for molecular interactions at the cell 
surface. These interactions mediate cell adhesion, fertilization, cell growth and 
differentiation, immunological processes, blood clotting, and hostpathogen interactions, 




Biologically significant carbohydrates usually exist as complicated oligomers or 
polymers, or in conjugation with other biomolecules to form bioconjugates such as 
glycolipids, glycoproteins, or glycosylphosphatidylinositol (GPI) anchors.
3
 In order to 
systematically identify and evaluate the roles of carbohydrates, glycobiologists need 




molecules from nature in high purity is still difficult due to their low abundance and 
heterogeneity. Therefore, developing practical synthetic approaches is an important 
method to afford pure carbohydrates in considerable quantities. 
The synthesis of glycosides always includes the regioselective and stereoselective 
construction of glycosidic bonds between glycosyl donors and acceptors, a process called 
glycosylation. Although considerable effort has been expended and progress has been 
made in developing efficient glycosylation approaches,
4–9
 the rapid construction of 
complex oligosaccharides or glycoconjugates with specific structures still remains 
challenging. Carbohydrate building blocks are present in more than one form (pyranose 
and furanose forms), and the variations of their size, configuration, connectivity, and 
spatial arrangement leads to diverse structures ranging from monosaccharides to 
oligosaccharides to highly branched polysaccharides and glycodendrimers. Each sugar 
unit is a unique stereogenic center, and the stereochemical control of the glycosidic 
connections requires precise design and prudent manipulation. Furthermore, from the 
mechanistic viewpoint, the process also lacks generality and consistency in 
rationalization of the glycosylation reactions.
10
 The glycosylation process usually initiates 
from the activation of a donor and via glycosyl oxacarbenium ion formation, which is 
reacted or coordinated with a counterion to form a covalent intermediate, or an 
equilibrating close-contact and loosely bound ion pair. These covalent intermediates or 
ion-pairs react with an acceptor in either SN1-like or SN2-like pathways to afford the 
corresponding products. During this process, many factors including donor type, 
promoter, protecting group, solvent, concentration, temperature, etc., are capable of 




factors will dominate the outcomes.
11, 12
 Therefore, proposing a comprehensive 
glycosylation method is a challenging task. 
Among the various glycosidic linkages, the O-glycosidic linkage is one of the 
representative linkage types based on its high generality and abundance in nature. 
Typically, the O-glycosides can be classified into either 1,2-cis- and 1,2-trans-O-
glycosides or α- and β-O-glycosides. 1,2-cis-O-Glycosides are generally α-O-glycosides, 
but there are exceptions such as α-O-mannosides and α-O-arabinosides, which belong to 
1,2-trans-O-glycosides. The α or β designation is based on the stereochemical 
relationship between the anomeric center (C-1) and the configuration of the highest 
numbered stereogenic center at the hemiacetal stage. If the hydroxyl groups bound to this 
center are cis to the substituent at the highest-numbered stereocenter, this anomer is 
called the α-anomer, otherwise the one with a trans relationship is called the β-anomer.
1
 
Several typical glycoside configurations are shown in Figure 1.1. Sometimes if the 2-
hydroxyl group is replaced by hydrogen, such as in 2-deoxyglycosides and sialosides, we 
no longer define them as 1,2-cis or 1,2-trans glycosides, and they are referred to as α- and 
β-glycosides. Both 1,2-cis and 1,2-trans glycosidic linkages are essential and 
indispensable in natural compounds, but the extremely difficult syntheses of 1,2-cis 
glycosidic linkages are barriers and could be encountered in many carbohydrate 
syntheses. The management of these difficulties is the focus of this review.
13
 
1,2-cis-O-Glycosidic linkages can be found in many oligosaccharides or 
glycoconjugates of high biological importance and therapeutic potential. Several typical 
naturally occurring oligosaccharides and glycolipids comprising 1,2-cis-O-glycosidic 


















series, which is a current target for tumor-specific antigen, have the α-linked galactosyl 
residue.
14
 Simplexide, another kind of glycolipid of marine origin with immunological 
potential, also consists of an α-D-glucosyl-(1→4)-β-D-(1→6)-galactosyl disaccharide 
residue.
15
 The bacterium Azospirillum brasilense SR80 consists of a lipopolysaccharide 
with an O-tetrasaccharide repeating unit, which contains a 2-O-(α-L-fucopyranosyl)-α-D-
galactosyl-(1→3)-β-D-galactosyl residue.
16
 The capsular polysaccharide A of Bacteroides 
fragilis NCTC 9343, which has been shown in mediating the formation of intra-
abdominal abscesses in experimental animal models, is composed of a 1,2-cis-
glycosaminoglycan motif.
17
 Clostridium difficile, which triggers nosocomial infections, 
has been found to express glycans containing 1,2-cis-linkage on the bacterial cell 
surface.
18
 Several asymmetrically branched N-glycans bearing 1,2-cis-β-D-mannoside 
residues are important synthetic targets to represent glycan structures of those found on 




There are several methods that can be applied to govern the stereochemistry of 
glycosylation reaction. The most general method is to put specific protecting groups on 
glycosyl donors. Various protecting groups have been developed and applied to afford 
desired stereochemical glycosides. Generally, they can participate in the formation of the 
oxacarbenium ions by either forming a covalent acetal bond, or by molecular interaction 
such as hydrogen bonding, or by steric effects to steer a specific nucleophilic attack 
pathway. For example, an acyl group on C-2 usually forms an acyloxonium ion with the 
anomeric center to reliably achieve 1,2-trans glycosides, which is called neighboring-








Figure 1.2 Representative naturally occurring oligosaccharides and glycolipids 






glycosidic bonds. Some kind of remote protecting groups, such as picolinoyl and 2-
quinolinecarbonyl groups,
20, 21
 have been demonstrated to guide the 1,2-cis 
stereoselectivity of glycosylation via hydrogen-bonding effects. Moreover, several bulky 





powerful 1,2-cis-directing groups, which have been extensively applied in the 
construction of the α-linkage in galactosides and the β-linkage in mannosides. Besides 
using an effective protecting group, the application of nucleophilic ether solvents, such as 
diethyl ether, dioxane, and tetrahydrofuran, are also highly regarded to facilitate the 1,2-
cis-stereoselectivity of glycosylation under different glycosylation conditions.
24, 25
 
Recently, I reported a straightforward 1,2-cis-alkyl glycosylation strategy by utilizing 
unprotected thiophenol glycosyl donors, which were glycosylated with a variety of 
reactive acceptors to make the corresponding 1,2-cis-O-glycosides in moderate to high 
yield and selectivity (see Chapter 2).
26
 
This overview focuses on the advances that have been developed to rise to the 
challenge of stereoselective glycosylation, especially of the 1,2-cis-O-glycosylation. The 
aim of this perspective is to overview (i) the application of diverse glycosyl donors and 
activation conditions on 1,2-cis-O-glycosylation, (ii) the influence of various protecting 
groups on 1,2-cis-O-glycosylation, and (iii) outlook of the 1,2-cis-O-glycosylation 
methods. 
1.2. Glycosyl Donors and Their Applications in 1,2-cis-Glycosylations 
1.2.1 Glycosyl halides 
In 1901, glycosyl chlorides and glycosyl bromides were first introduced as 
glycosylation agents by Wilhelm Koenigs and Eduard Knorr,
27




is still widely used nowadays in the stereospecific synthesis of glycosides. Heavy metal 
salts, such as Ag2O, Ag2CO3, AgOTf, AgClO4, HgBr2, Hg(CN)2, HgO or CdCO3 usually 
serve as promoters in this reaction.
1
 Another benefit of using metal carbonates and oxides 
as activators is they are also acid scavengers, which can neutralize the acid released in the 
glycosylation reaction. Sometimes organic bases, for example s-collidine, lutidine, 
tetramethylurea, and the sterically hindered 2,6-di-tert-butyl-4-methylpyridine (DTBMP) 
and 2,4,6-tri-tert-butylpyrimidine (TTBP) also perform the same function.
2
 
Besides a leaving group, the halide ion is also used as a stereodirecting agent. 
Lemieux introduced halide-ion catalyzed glycosylation (Scheme 1.1a), which is to 
combine promoters such as Et4NBr or Bu4NBr with Hünig’s base to yield high 
stereoselectivity of 1,2-cis glycosides.
28, 29
 During this process, the generated bromide ion 
(Br
−
) performs as a nucleophile to convert α-glucosyl bromide 1 into β form 2, which was 
glycosylated with an acceptor to give 1,2-cis-α-glucoside 3. However, the Lemieux 
glycosylation often takes long reaction times (>2 days), and only applies to reactive 
glycosyl halides and acceptors. Fortunately, these drawbacks can be avoided by using 
alternate glycosyl donors, to generate glycosyl halides in situ, such as to activate 




 to progress through 
glycosyl halide intermediates. 
Although these were the only donor choices for a long period of time, glycosyl 
halides are now losing their prevalence in glycosylation reactions. They suffer from two 
weaknesses: first, equimolar amount of poisonous, costly and often moisture- and light-
sensitive heavy metal reagents are utilized as promoters; second, the lability of glycosyl 





















activity of the very sensitive anomeric halides. These drawbacks can be circumvented by 
either applying benzyl or silyl protecting groups on glycosyl halide donors, or by using 
more stable donors such as thioglysides as effective stereospecific glycosylation methods 
that have been developed. 
Although glycosyl iodides were first prepared many years ago,
32
 their utility as 
glycosyl donors has not been fully explored until recent decades, which is due to their 
instability and high reactivity. The halide ion-catalyzed glycosylation method paves way 
for their in situ preparation, and they have showed delightful properties in reaction rate, 
efficiency, and stereoselectivity.
33–35
 Most reported glycosylation reactions by glycosyl 
iodide donors are equipped with arming (activating) protecting groups, usually O-benzyl, 
O-trimethylsilyl, or other electron-donating groups.
36
 The direct nucleophilic 
displacement of an anomeric iodide by an acceptor via an SN2 process could achieve a 
straightforward synthesis of a 1,2-cis glycosyl linkage, which avoids the introduction of 
stereodirecting groups that require further removal. For example, benzylated glycosyl 
acetate 4 can be activated by iodotrimethylsilane (TMSI) to yield the α-glycosyl iodide 5. 
Without isolation, α-glycosyl iodide is activated by TBAI and Hünig’s base to produce β-
glycosyl iodide 6 in situ, and subsequent axial attack on the anomeric center affords the 
α-glycoside 7 in high stereoselectivity (Scheme 1.1b).
37, 38
 Besides the benzyl protecting 
group, the trimethyl silylated glycosyl iodide 8 can also be synthesized and applied in 
constructing the biologically active α-D-cholesterylglycoside 10 in high 1,2-cis selectivity 
(Scheme 1.1c).
39
 Because of their high reactivity and instability, methods are needed to 
generate glycosyl iodides in situ, and further improvements are expected to increase their 




1.2.2 Glycosyl imidates 
In glycosyl imidates, the anomeric oxygen atom is derivatized to a labile leaving 
group, which can be readily removed by Lewis acid activators such as TMSOTf or 
BF3·OEt2. Sinaÿ prepared the first β-O-glycosyl acetimidates by treating benzylated 
glycosyl chlorides 11 with N-methylacetamide,
40
 and applied them in the construction of 
the blood group B determinant. The acetimidates 12 and 13 were each glycosylated with 
glycosyl acceptors 16 and 14, respectively, by the promotion of pTsOH, and 1,2-cis 
glycoside 17 was thus synthesized in excellent stereoselectivity (Scheme 1.2).
41, 42
 
In the 1980s, Schmidt reported O-glycosyl trichloroacetimidates and O-glycosyl 
trifluoroacetimidates as advanced imidate donors with better general applicability.
43
 After 
that, a series of N-substituted O-glycosyl trihaloacetimidates was synthesized from the 
corresponding glycosyl hemiacetals and trihaloacetonitrile or N-substituted 
trihaloacetimidoyl halides in a basic medium.
44
 Generally, trichloroacetimidate donors 
are more competent than trifluoroacetimidate donors with respect to reactivity and 
reaction yield, while in some specific cases
45, 46
 O-glycosyl N-phenyl-
trifluoroacetimidates are more reactive. There are several factors including the existence 
of a substituent, the basicity and/or the size of the leaving group, and its conformational 
change synergistically determining the donor efficiency.
47
  
The glycosylations with trichloroacetimidates are usually carried out under acidic 
conditions, and various Lewis acids have been tested and demonstrated, ranging from 






 for the specific 
activation of armed and disarmed O-glycosyl donors, respectively. The activation of N-

















systems include Bi(OTf)3, I2/Et3SiH, and TMSB(C6F5)4.
46, 50
 For the purpose of reaching 
desired 1,2-cis-stereoselectivity, the glycosylation conditions need to be precisely 
controlled, usually assisted by the use of non-participating protecting groups (benzyl 
group), nonpolar solvents, mild Lewis acid catalysts (BF3·OEt2), and low reaction 
temperatures. Such conditions favor the SN2 processes, and β-trichloroacetimidate will 
preferentially provide α-glycosides. If more powerful conditions were applied, such as 
using strong acid catalysts (TMSOTf, TfOH), higher temperature and more polar 
solvents, both α- and β-trichloroacetimidates would generate the thermodynamically 
stable products, which are the α-glycosides in general. Besides the glycosylation 
conditions, the nature of the counter anion of the Lewis acid also has an influence on the 
stereoselectivity. For example, in some specific cases HClO4 favors the formation of α-




The O-glycosyl trihaloacetimidate donors have been extensively employed in the 
synthesis of 1,2-cis-O-glycosides. Benzylated O-galactosyl trichloroacetimidate 18 was 
glycosylated with the acceptor 19 to exclusively furnish the α-(1→4)-linked trisaccharide 
20, for the synthesis of oligosaccharide moieties 21 of a globotriaosylceramide (Scheme 
1.3a).
52
 They were also used in the stereoselective construction of α-(1→6)-linked 
saccharides such as verbascose, raffinose or sucrose (Scheme 1.3b).
53
 Benzylated O-
glucosyl trichloroacetimidates also displayed comparable properties. The glycosylations 
can be successfully realized with either 2-, 3-, 4- or 6-OH on glycosyl acceptors in the 
presence of TMSOTf at low reaction temperature, in order to obtain predominantly α-
linked oligosaccharides.
54















trifluoroacetimidate 24b, in some specific cases, is superior to trichloroacetimidate 24a, 




The disadvantages of this method still exist: the high reactivity and lability of 
glycosyl trichloroacetimidates can give rise to side reactions during glycosylations; the 
donor may decompose during long-time storage; the rearrangement of the donor may 
occur to produce the non-reactive glycosyl trichloroacetamide. All these will lead to low 
glycosylation yields, side products, and challenges in purification. Moreover, the 
structural characterization of donors could be complicated by their invertomers, and 
further aggravated by the splitting of the carbon signals by adjacent fluorine.
4–9
 
1.2.3 Glycosyl phosphates and phosphites 
The first synthesis of glycosyl diphenyl phosphates as effective glycosyl donors 
was reported in 1989.
56
 After that, many glycosyl donors bearing phosphorus leaving 
groups were developed by adopting different substituents on the phosphorus atom.
57, 58
 In 
most circumstances, both α- and β-glycosyl phosphate donors are easy to prepare, store, 
and manipulate; yet the glycosylation properties were found inferior to the corresponding 
O-glycosyl trichloroacetimidates. The traditional reaction method was to use TMSOTf as 
the promoter in at least a stoichiometric amount, which is due to the formation of an 
equal amount of silyl phosphate to be the driving force of glycosylation. Recently, 
perchloric acid was employed in only a catalytic amount as an efficient activator, and 
enhanced α-selectivity was obtained.
59
 
Likewise, the glycosyl phosphate and phosphite donors are capable of forming 





Scheme 1.4  Glycoside syntheses with glycosyl phosphates (a, b) and glycosyl phosphite 






27 (mixed isomers with high α) was reported as the donor to glycosylate with glycosyl 
acceptor 28 to provide glycoside 29 in good yields and α-selectivity upon activation with 
catalytic amount of TMSClO4 or HClO4 in a dioxane/Et2O mixed solvent (Scheme 
1.4a).
60
 This strategy has also been practiced in the preparation of α-galactosylceramide 
KRN 7000, a ligand for natural killer T cells activation on antigen-presenting cells. 
Benzylated galactosyl diphenyl phosphate 30 was coupled with the ceramide acceptor 31 
under a catalytic amount of HClO4 in dioxane, and the glycoside 32 was formed in 
respectable yield and α-selectivity (Scheme 1.4b).
59
 It is believed that during the 
glycosylation process a contact ion pair (CIP) 35 is formed with an oxocarbenium ion and 
a perchlorate counter ion after the cleavage of the phosphate group, and ethereal solvent 
facilitates the formation of solvent-separated ion pair (SSIP) 36, which favors the axial 




Glycosyl phosphite exhibits the preference in α-glycosylations as well. Glycosyl 
diethyl phosphite 38 was reacted with the acceptor 28 to predominantly furnish α-
glycoside 29 under the activation of 2,6-di-tert-butylpyridinium iodide (DTBPI) and 
TBAI. The glycosyl iodides were supposed to be generated as intermediates during the in 
situ anomerization process (Scheme 1.4d).
63
 
1.2.4 Thioglycosides  
Thioglycosides are amongst the most popular types of glycosyl donors in 
oligosaccharide synthesis from their first preparation over a century ago.
64
 
Thioglycosides have many benefits as glycosyl donors, which include long shelf life for 




group operation, favorable state as crystalline, and most importantly, amenability to 
desired chemoselective transformations when necessary. Therefore, thioglycosides satisfy 





Accordingly, a great variety of strategies have been developed for the synthesis of 
thioglycosides. The most popular method for thioglycoside preparation is to treat per-O-
acetylated carbohydrates with thiols such as thioethanol or thiophenol in the presence of 
Lewis acids, usually BF3·OEt2, to predominantly furnish 1,2-trans thioglycosyl donors.
65
 
They have also been prepared by a two-step procedure that involves a nucleophilic 
displacement of acetylated glycosyl halides to give the corresponding glycosyl 
thioacetates, followed by alkylation/arylation of the in situ generated thiols by selective 
S-deacetylation.
66
 This protocol is quite versatile when different alkyl/aryl thiol 
glycosides or S-linked disaccharides need to be synthesized.
67
 The acetylated 
thioglycosides thus prepared can survive in deacylation and many other protecting group 
manipulations, whereas glycosyl bromides and glycosyl trichloroacetimidates cannot.  
A wide range of activation systems for thioglycoside donors has evolved as well. 
The use of iodonium ions generated from N-iodosuccinimide (NIS) with a catalytic dose 
of triflic acid (TfOH), which was first reported in 1990, has been regarded as the 
preferred method to activate thioglycosides.
68
 Since then, the activation ability of 
iodonium ions on thioglycosides has been demonstrated by many successful applications 
with variations, and besides, many other thiophilic promoters have been developed. For 









 etc., as alternatives to TfOH for the activation of 






interhalogen compounds (ICl or IBr),
74
 or iodine (I2)
75
 functions similarly as substituent 
halo sources. 1-Fluoropyridinium triflates were also reported
76
 as versatile promoters in 
the transformation of thioglycosides to O-glycosides. All these activation systems rely on 
the intrinsic soft nucleophilicity and especially the halophilicity of the sulfur atom in the 
thioglycosides. The glycosylation process initiates from the activation with soft 
electrophilic reagents (halogen in such cases) and the formation of a sulfonium ion, 
which is a better leaving group. Cleavage of the sulfonium ion leads to the formation of a 
oxocarbenium ion as a common intermediate in glycosylation, and the following 
nucleophilic addition by the glycosyl acceptor affords the O-glycoside (Scheme 1.5a).
77
 
Recently another type of soft electrophile, the organo-sulfur compounds, has been 
evaluated as valuable promoters for the activation of thioglycosides. Representative 

















. Since the sulfinyl/triflic anhydride systems are able to 
preactivate thioglycosides at low temperatures, the thioglycosides can be activated in the 
presence of another and be treated as glycosyl acceptors as well. Besides, the relative 
stability of thioglycosides facilitates the selective glycosylation of glycosyl imidate 
donors. These features have often been applied in the iterative and one-pot synthesis of 
complex oligosaccharides (Scheme 1.5b, Scheme 1.6a).
4-9
 
The applications of thioglycosides in 1,2-cis-glycosylation reactions are 
frequently reported. For example, stereoselective construction of 1,2-cis-α-O-glycosidic 








Scheme 1.5 Glycosylation by a thioglycoside via the activation of an electrophile (a), and 











glycosides in the presence of iodine as an efficient promoter.
84
 Thiogalactoside was also 
reported to be glycosylated with acceptors by using BSM/Tf2O in a preactive one-pot 
synthesis fashion, to give the trisaccharide 48 bearing a 1,2-cis linkage as analogue of a 
tumor-associated antigen IsoGb3 (Scheme 1.6a).
85
 The unprotected deoxythioglycoside 
49 was coupled with alcohols under the assistance of DDQ and long-wavelength UV 
irradiation to effectively give α-O-glycoside 50α as the major product (Scheme 1.6b). 
Specifically, p-methoxyboronic acid was demonstrated to temporarily protect the 1,3-diol 
(C-4 and C-6 positions) and increase the reaction yields.
86
 Very recently, a method using 
thioglycoside donors was developed for the highly selective O-glycosylation. The 
thioglycoside 51 was activated with Ph2SO/Tf2O, followed by TBAI, to possibly generate 
a glycosyl iodide intermediate that undergoes stereoselective 1,2-cis-α-glycosylation in 
high yield. This method permits iterative oligosaccharide synthesis (Scheme 1.6c) as 




In conclusion, lots of attention and effort have been generated in the preparation 
and activation of thioglycosides, and many strategies have been proposed during the past 
decade. Since thioglycosides are representative glycosyl donors with many benefits, they 
were designed to play a key role in oligosaccharide synthesis. Therefore, advanced 
approaches, which emphasize regio- and stereoselective reactions in high yield with easy 







1.2.5 Other glycosyl donors and activators 
The previous sections review the glycosyl donors most typically used in 
oligosaccharide synthesis and especially their applications in 1,2-cis-O-glycosylations. 
Although these glycosylation strategies have offered significant advances for 
chemselective glycosidic bond formation, it is still necessary to evaluate other less 
commonly used glycosyl donors. Adopting dissimilar glycosyl donors alters activation 
patterns and glycosylation potential, which might be vital to solve a particular 
glycosylation problem. 




 aglycone, bear properties of 
both a thioglycoside and a glycosyl imidate. Glycosyl thioimidates are efficient donors, 
and examples such as S-benzoxazolyl (SBox) glycoside
88
 and S-thiazolinyl (STaz) 
glycoside
89
 have been employed in the 1,2-cis-O-glycosylation with complete 
stereoselectivity (Scheme 1.7a). The high stability of glycosyl thioimidates makes them 
competent to tolerate harsh reaction conditions that sometimes have to be designated for 
the activation of other glycosyl donors, and these properties popularize them in the 
synthesis of complex oligosaccharide.
90
 Recently, benzylated glycosyl boranophosphate 
58 was developed with modified reactivity as a glycosyl phosphate analog. The 
displacement of the P=O moiety by a PBH3 group enables the donor to be stable in the 
presence of Lewis acids, while its specific activation can be easily fulfilled by the trityl 
cation (Tr
+
). A trityl salt such as trityl N,N-bis(trifluoromethanesulfonic)imidate (TrNTf2) 
can be used, while the reaction can also be carried out with the O-trityl ether 59 that 
serves as both the Tr
+
 source and the glycosyl acceptor (Scheme 1.7b), which provides 
improved O-glycosylation yields and 1,2-cis stereoselectivity as well.
91

















orthoesters, which are usually intermediates in glycosylation processes, can also give 1,2- 
cis-glycosides through rearrangement.
45, 92, 93
 2-Nitroglycals are particularly valuable in 
the cis-formation of 2-acetamido galactosides.
94
 Even if those inactive glycosides such as 
methyl glycoside 60 and 1-hydroxy sugars are now used as glycosyl donors under 
specific conditions with moderate to high reactivity (Scheme 1.7c).
95
 
1.3. 1,2-cis-Directing Protecting Groups 
Nowadays, the role of protecting groups in carbohydrate chemistry is no longer 
limited to simply provide blocking of hydroxyl groups, because it has been realized that 
protecting groups can have a pronounced impact on the reactivities of both glycosyl 
donors and acceptors, as well as on the stereoselectivity of the glycosylation. This section 
will focus on the formation of 1,2-cis glycosidic bonds via installation of special 
protecting groups that preferentially direct the 1,2-cis-stereoselective. Based on the 
directing effects, the protecting groups are typically classified into two major categories, 
which are 1,2-cis-directing through electronic effects (Section 1.3.1) and through 
torsional effects (Section 1.3.2). Besides, unprotected glycosyl donors and their 
applications in 1,2-cis-glycoside synthesis have also been reported (Section 1.3.3). 
1.3.1 1,2-cis-Directing protecting groups through electronic effects 
Ether protecting groups are often used in the synthesis of 1,2-cis gluco- or 
galactosides for the neighboring hydroxyl protection. They are generally treated as 
nonparticipating protecting groups, and the 1,2-cis selectivity is achieved by the anomeric 
effect. Similarly, results can also be reached by aryl sulfonyl protecting groups, 
especially in the construction of β-mannosyl (Scheme 1.8a) and rhamnosyl glycosides. 





Scheme 1.8 Stereoselective synthesis through electronic effects by a neighboring 




Scheme 1.9 Stereoselective glycosylation with (S)-(ethoxycarbonyl)benzyl-protected 
glycosyl donor (a), and neighboring-group participation by an (S) auxiliary at C-2 leading 




When the donor is activated, the strong dipole effect facilitates the formation of a 
flattened twist-boat intermediate (Scheme 1.8b), and it is attacked favorably from the β 
face to give a 1,2-cis-glycoside.
96, 97
 
A new general strategy was developed for the formation of 1,2-cis-glycosidic 
linkages by introducing a neighboring auxiliary group at the 2-O-position, such as (S)- 
ethoxycarbonyl)benzyl chiral substituent depicted in Scheme 1.9a.
98
 The addition of the 
ethoxycarbonyl group from the chiral auxiliary to the anomeric center, which is called 
neighboring-group participation, leads to the formation of a stable dioxolenium ion. It is 
expected that the (S)-stereochemistry of the phenyl group would occupy the equatorial 
face, which prevents unfavorable 1,3-diaxial steric interactions. Therefore, the attack of 
the dioxolenium ion by acceptors could only be feasible from the bottom face to give α-
glycosides (Scheme 1.9b). Instead, β-glycosides can be readily afforded with the help of 
an R-configuration auxiliary. Moreover, the introduction of an electron-withdrawing 
group at the C-3 position could destabilize the oxacarbenium ion and facilitate the 
auxiliary group participation as well as the formation of α-glycosides. However, a 
drawback of this strategy is that an auxiliary group has to be installed on the glycosyl 
donor and cleaved after glycosylation, which requires relatively harsh conditions and 
tedious operations. 
Recently, a simplified approach was proposed based on the virtue of a 
neighboring auxiliary group towards the preparation of 1,2-cis-glycosides. The glucosyl 
1,2-oxathiane ether was made from thioglucoside 69, and its further oxidation gave 























the donor with various glycosyl acceptors furnished corresponding disaccharides in high 
yields and 1,2-cis stereoselectivity (Scheme 1.10). The new donor is capable of 
withstanding many kinds of reaction conditions with respect to protecting group 
manipulations, and it has been successfully applied in the synthesis of a branched 
glucoside as a polysaccharide derivative isolated form a natural fungi.
99
 
The influence of remote substituents on configuration of the anomeric center 
during glycosylations has been exploited in recent years as well. Several kinds of 




 groups to 
deliberately designed picolinyl (Pic)
102
 and picoloyl (Pico)
103
 protecting groups, are 
carefully studied and determined to be effective in the stereo-formation of glycosidic 
bonds. For example, a comparative study
100
 revealed that when trichloroacetimidate 
mannoside donors contain electron-withdrawing substituents such as an acetyl or benzoyl 
group at the C-3 position, their glycosylations with primary glycosyl acceptors could 
provide the disaccharides in great yields and 1,2-cis-selectivity. However, if the electron-
withdrawing substituent at C-3 is changed to benzylsulfonyl, the stereoselectivity of the 
corresponding disaccharide would be inverted to 1,2-trans-selectivity. Recently, a 
parallel study
104
 was carried out on the glycosylations of glucosides with both 
conformationally restricted and non-restricted glucosyl donors. The results indicated that 
when the glucosyl N-phenyltrifluoroacetimidate donors bear acetyl groups at C-3 or C-6, 
the glycosylations with acceptors were accomplished in high yields and 1,2-cis 
selectivity. When the acetyl group at C-6 was switched to a benzoyl group, a further 
selectivity increase was observed. Comparable yields and selectivity were also applied to 




experimental results support the hypothesis that electron-withdrawing or sterically bulky 
groups, specifically those at C-6, favor 1,2-cis-glycosylation. The protecting groups 
electronically or sterically shield the top face of the pyranose rings, and facilitate the 
nucleophilic addition from the opposite face to afford 1,2-cis-glycosides.
105
 
The study of 2-azido-2-deoxy glycosyl donors showed a distinctive relationship 
between the remote protecting groups and stereoselectivity of glycosylations.
106
 It was 
observed that acetyl substituents at C-3 and C-6 positions on GlcN3 donors directed α-
glycosylations, whereas acetyl group at C-4 was more β-directing.
107
 The application of 
2-azidomannouronate ester donor in 1,2-cis-glycosylation was investigated as well.
108, 109
 
The donor could be coupled with a glycosyl acceptor with the activation of Ph2SO and 
TfOH at low temperature to give predominantly 1,2-cis-glycosides. The proposed 
mechanism states that the oxacarbenium ion is formed as an intermediate in association 
with the triflate counterion. Meanwhile, the strong electron-withdrawing carboxylate 
group on C-5 dominates a pseudo-axial location and stabilizes the positive charge on the 
intermediate, which expedites the following nucleophile attack from the bottom face and 
provides 1,2-cis selectivity exclusively. 
In addition, an innovative stereodirecting glycosylation strategy, which is defined 
as H-bond-mediated aglycone delivery (HAD), has been carefully designed and applied 
with the assistance of specific protecting groups such as picolinyl (Pic) and picoloyl 
(Pico) groups.
20
 When incorporating these substituents at C-3 or C-4, a hydrogen bond is 
formed between the picolinyl nitrogen with the oxygen of the acceptor at the syn face, 
and a high stereoselectivity is achieved. The applicability of this strategy was 




glucosyl donor, 3-O-picoloyl mannosyl donor, 5-O-(2-quinolinecarbonyl) arabinosyl 
donor, as well as the 6-O-picoloylated 2-deoxy glycosyl donors, all successfully 
contributed to 1,2-cis glycosidic bond formation. Besides, it was observed that this 
strategy is particularly effective under dilute conditions (5 mM). The use of 4-O-picoloyl 
glucosyl donors provides faster and increased 1,2-cis selectivity compared with those 
acquired at higher concentration.
103
  
1.3.2 1,2-cis-Directing protecting groups through conformational constraining 
effects 
Recently, much attention has been paid to the conformationally constrained 
glycosyl donors in effective glycosylations. Since the first report
110
 of the deactivation 
effect of a cyclic acetal group on glycoside donors, conformationally restricted protecting 
groups have been largely applied
101
 to modulate the reactivity of donors, especially to 
enhance the stereoselectivity and enable orthogonal oligosaccharide syntheses that 
involve considerable synthetic challenge. Conformational constraining protecting groups, 
which are usually cyclic bifunctional protecting groups, can confine the flexibility of the 
sugar ring and lock the donors to certain conformations. When the donors are activated, 
glycosyl oxocarbenium ions are generated with face discrimination, which makes them 
principally accessible from one side.  
The employment of 4,6-O-benzylidene protecting group has been demonstrated as 
a successful strategy of β-selective mannosylations (Scheme 1.11a).
111–114
 Early examples 
involve using 4,6-O-benzylidenate sulfoxide donors and thioglycoside donors to directly 
form β-mannosidic linkages. It was believed that the benzylidene protecting group 























additions had to be preferentially carried out from the β face.
115
 Subsequently, high β-
selective mannosylations were practiced with other types of mannosyl donors possessing 
4,6-O-benzylidene protections, such as TCAI, PTFA, phosphite, iodide and phthalate 
donors, and many of which were even activated by non-triflate promoters other than 
forming the mannosyl triflate intermediates.
55, 116–119
 Therefore, it has been rationalized 
that the high β-mannosylations are induced by a torsional effect imposed by the 
benzylidene group. The stereoselective glycosylation processes proceed via the formation 
of a conformationally constrained twist-boat structure intermediate, other than the α-
mannosyl triflate intermediate. This proposal accounts for the great β-stereoselectivity of 
4,6-O-benzylidene 2-deoxy-2-iodoglucosyl donors as well. However, it has to be added 
that other factors, including leaving groups, glycosyl acceptors, substituents at the 2-/3-




Besides its applications in β-mannosylations, the 4,6-O-benzylidene protecting 
group was also used in other kinds of glycosyl donors to achieve α-glycosylations. For 
instance, 4,6-O-benzylidene-protected thioglucoside donor 78 was glycosylated with 
various acceptors to give α-glucosides with excellent selectivities (Scheme 1.11b).
122
 We 
know that during the glycosylation processes, numerous intermediates with different 
reactivities and stabilities are likely to exist, and many factors can determine the 
compositions and equilibrium proportions. In such circumstances, however, the 
conformational constraining effect imposed by the benzylidene group still contributes a 
major impact towards the glycosylation pathways, and could be responsible for the 


















Inspired by the strong stereospecific effect of the 4,6-O-benzylidene group, the 
strategy of using a 2,3-O-carbonate group as a conformationally constraining protecting 
group has also been established.
123
 In many cases, 2,3-O-carbonate thioglucosides and 
thiogalactosides have been shown to be good α-glycosylating agents, but these reactions 
always relied on specific activators and/or solvent systems.
124
 Although neighboring-
group participation is unavailable due to the incorporated carbonate ring, some kinds of 
2,3-O-carbonate donors also present β-stereoselectivity and have been used in the 
synthesis of β-glycosides (Scheme 1.12a).
125
 Fortunately, there is not a huge gap for the 
transition from a β- to an α-stereodirecting effect, and the corresponding switching 
method has been developed. With the assistance of either a catalytic or stoichiometric 
amount of Lewis acid, the β-stereospecificity of 4,6-di-O-benzyl-2,3-O-carbonate 
thioglucoside was inverted completely to α-selectivity (Scheme 1.12b).
126
 Moreover, the 
carbonate group deactivates the glycosyl donors both electronically and 
conformationally. Thus, the disarming effect enables them to serve as acceptors at the 
same time in an orthogonal glycosylation synthesis, where chemoselective activations of 
other armed glycosyl donors can be performed. 
The 2,3-N,O-oxazolidinone group has been used as an α-directing group in 
glycosylation reactions as well, specifically in the preparation of α-linked 2-amino-2-
deoxyglycosides.
127
 However, side reactions may occur sometimes, and the nitrogen 
atom on the oxazolidinone group has the propensity to undergo N-glycosylation or N-
sulfenylation. Therefore, a revised method is to use N-acetylated oxazolidinone donors 
(Scheme 1.12c).
128
 The stereospecificity of the donors in glycosylations can also be 




acceptors, and the activation systems. For example, the N-acetylated oxazolidinone 
donors were β-stereoselective when applying the NIS/AgOTf activation system; when an 
excess amount of AgOTf was used, in situ anomerization would occur to generate α 
products. Meanwhile, the torsional oxazolidinone ring played a key role, as an endocyclic 
C-1–O-5 bond cleavage pathway was found to be operative.
129
 The employment of N-
benzyl-2,3-oxazolidinone thioglycosides as glycosyl donors for α-glycosylations was 
reported recently, and satisfactory yields and selectivities were observed.
130
  
Silyl groups are among the most frequently used protecting groups in 
carbohydrate synthesis based on their high stability and of easy operation. However, it 
was until the recent applications of di-tert-butylsilylene (DTBS) protecting group in 1,2-
cis-galactosylations that their stereodirecting ability had been widely recognized.
131, 132
 
Since then, cyclic bifunctional silyl protecting glycosyl donors had been largely applied 
in the stereoselective syntheses of glycosides.
133
 Compared with mono-substituted silyl 
protected donors, cyclic bifunctional silyl protecting groups exhibit stronger governance 
on the stereoselectivity of glycosylation through rigidifying the donor ring conformation 
and imposing steric hindrance during glycosylation. For example, the 1,1,3,3-
tetraisopropyldisiloxane-protected thiofructofuranoside 87 was synthesized as a 
stereospecific donor (Scheme 1.13a).
134
 The highly bulky silyl group blocks the α-face of 
the donor to guarantee a completely β-glycosylation with the glycosyl acceptor. 
The employment of DTBS-protected donors is becoming a popular method for the 
construction of 1,2-cis glycosidic bonds, especially in the syntheses of α-galactosides. It 
has been demonstrated that DTBS-protected galactosyl donors are able to glycosylate 
















neighboring participating groups such as benzoyl (Bz) or 2,2,2-trichlorethoxycarbonyl 
(Troc) were installed at C-2 (Scheme 1.13b), high α-selectivities were also observed, 






A plausible mechanism has 
been proposed to account for the powerful α-directing effect of DTBS group. As for the 
galactopyranoside, it has been demonstrated that the axially oriented oxygen at C-4 
contributes electrons to stabilize the generated oxocarbenium ion during the glycosylation 
process, which is called “through-space electron donation”.
135
 This effect steadies the 
intermediate and prevents the neighboring groups with moderate nucleophilicity from 
participating. Meanwhile, the bulky tert-butylsilylene group entails a closer positioning to 
the anomeric center, and prevents the nucleophilic acceptors to add from the β-side.
133
 
Besides its applications in galactosylations, the DTBS group was also incorporated into 
arabinofuranoside to obtain a conformationally constrained donor to control the anomeric 
configuration. Glycosylations were performed to have expected β-selectivity with many 
acceptors, which claimed its potential in the construction of β-arabinoside domains from 
lipoarabinomannan and mycobacterial arabinogalactan (Scheme 1.13c).
136, 137
 
1.3.3 Protective group free glycosylations  
Generally, a well-established glycosyl donor should contain the following 
properties, which are, (a) easy accessibility; (b) high generality for various alcohols and 
glycosyl acceptors; (c) applicability with alternative reaction conditions or catalysts; (d) 
high efficiency on both yield and stereoselectivity. Adopting unprotected glycosyl donors 
directly into the glycosylations is an appealing strategy. Unprotected glycosyl donors 
often hold higher reactivities, and their usage avoids the cumbersome protection and 




the past century, the original Fischer glycosidation method is still the most utilized 
method for glycosylations with simple alcohols. Fischer glycosidation refers to the 
reaction of a cyclic hemiacetal (a free sugar) with an alcohol to form a glycoside by the 
catalysis of an acid, which named after Emil Hermann Fischer who devloped this method 
a century ago (Scheme 1.14a).
138
 The Fischer glycosidation involves an equilibrium 
process, and usually it is shifted by the treatment of an excess amount of alcohol, acid 
catalyst, high temperature and long reaction times. This strategy often provides a mixture 
of stereoisomeric products, of which the alpha anomer is normally the major product, as 
it is the most thermodynamically stable product owing to the anomeric effect. Up to now, 
the traditional Fischer glycosidation has been enhanced by exploiting different kinds of 
acid catalysts
139





However, since free carbohydrates have limited solubility in alcohols, 
it usually requires harsh conditions (e.g., high temperature, microwave, ultrasonication) 
to push the reaction, which results in decomposition of the products, encroachment of 
side products, and tedious separation processes. 
 




Some kinds of unprotected glycosyl donors, such as glycosyl 
trichloroacetimidates and 3-methoxy-2-pyridyloxy (MOP) glycosyl donors, were applied 
into α-stereodiecting glycosylations.
142
 However, drawbacks including low stability and 
limited generality, impair their versatility. Later, advanced unprotected glycosyl donors 
were prepared to rise to the challenges. The glycosylations using unprotected alkynyl 
glycosyl donors under the activation of gold(III) have been reported (Scheme 1.14b).
143
 
Several terminal alkynyl glycosides were glycosylated with various primary alcohols in 
excess amount under reflux in acetonitrile and 5% AuCl3. The 2-butynyl glycosides were 
most reactive, giving good yields with moderate to high α-selectivities. The secondary 
alcohols were also tested but showed reduced efficiency. 
A rencent study investigated the photoinduced O-glycosylation of unprotected 
deoxythioglycosides (Scheme 1.6b). It was revealed that glycosylations could be 
performed with alcohols in the presence of DDQ and long-wavelength UV irradiation to 
give respectable yields and α-selectivities. It has also been demonstrated that p-
methoxyboronic acid could temporarily protect the 1,3-diols (C-4 and C-6 positions) to 
prevent self-coupling of the donor or formation of a 1,6-anhydroglycoside.
86
 
1.4. Conclusions and Outlook 
The advances of chemical glycosylation strategies summarized herein have 
significantly enriched our tactics to build various glycosidic linkages and access complex 
oligosaccharides and glycoconjugates of great biological importance. Nevertheless, it is 
still too early to claim that all roughness associated with glycosidic bond formation has 
been smoothed. Carbohydrates are amongst the most complicated biomolecule systems in 




activator/catalyst, and reaction conditions, are influential or decisive to the glycosylation 
outcomes. Even for the construction of a simple oligosaccharide molecule, a carefully 
designed synthetic route and a meticulous experimental operation are often required to 
obtain the target molecule in high yield and selectivity. Therefore, development of 
general, efficient, and flexible strategies to achieve the intrinsic organizational diversity 
of carbohydrates is still imperative. 
How do we reach this ultimate goal? From my perspective, a continuous 
screening of alternative glycosyl donors and protecting groups may not spark 
fundamental advancement of the current approaches for glycosylations. Instead, more 
concerns should be put into the discovery of glycosylation mechanistic principles and the 
driving forces behind these reactions. There has been proposed many sorts of 
glycosylation pathways and intermediates, such as generations of oxacarbenium triflate 
ion-pair and solvent separated ion-pair, conformation-dependent reactivity, H-bonding 
stereodirecting effects, and so forth, but none of these can be completely demonstrated. A 
comprehensive understanding of glycosylation mechanisms will be beneficial for further 
advances in glycosylations and to generate innovations, such as the development of 
“enzyme-like catalysts”. The enzyme-like catalyst will not only have comparable 
properties as enzymes such as transglycosidases or glycosyl transferases with high 
selectivities and a minimum of protections, but these reagents also exhibit superior 
glycosylation performance with respect to stability and efficiency, and availability in 
industrial production. It could specifically detect the target glycosides, and provide the 
platform and the activation required. It is inspiring that some preliminary attempts have 







1. Lindhorst, T. K. Essentials of Carbohydrate Chemistry and Biochemistry. Third 
edition. Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, GER, 2007. 
2. Osborn, H. M. I. Carbohydrates. Elsevier Science Ltd.: Oxford, UK, 2003. 
3. Tiwari, V. K.; Mishra, B. B. Opportunity, Challenge and Scope of Natural 
Products in Medicinal Chemistry. Research Signpost: Kerala, IN, 2011. 
4. Zhu, X.; Schmidt, R. R. New principles for glycoside-bond formation. Angew. 
Chem. Int. Ed. 2009, 48, 1900-1934. 
5. Demchenko, A. V. Stereoselective chemical 1,2-cis-O-glycosylation: From 'sugar 
ray' to modern techniques of the 21st century. Synlett 2003, 1225-1240. 
6. Toshima, K. Novel glycosylation methods and their application to natural 
products synthesis. Carbohydr. Res. 2006, 341, 1282-1297. 
7. Seeberger, P. H. Automated oligosaccharide synthesis. Chem. Soc. Rev. 2008, 37, 
19-28. 
8. Hsu, C.-H.; Hung, S.-C.; Wu, C.-Y.; Wong, C.-H. Toward automated 
oligosaccharide synthesis. Angew. Chem. Int. Ed. 2011, 50, 11872-11923. 
9. Yang, L.; Qin, Q.; Ye, X.-S. Preactivation: An alternative strategy in 
stereoselective glycosylation and oligosaccharide synthesis. Asian J. Org. Chem. 2013, 2, 
30-49. 
10. Premathilake, H. D.; Demchenko, A. V. Superarmed and superdisarmed building 
blocks in expeditious oligosaccharide synthesis. Top. Curr. Chem. 2011, 301, 189-221. 
11. Werz, D. B.; Vidal, S. Modern Synthetic Methods in Carbohydrate Chemistry. 




12. Crotti, S.; Adamo, R. New strategies for the synthesis of bio-medically relevant 
oligosaccharides: Recent updates on 1,2-cis-O-glycosylation and α-O-sialylation Curr. 
Org. Synth. 2013, 10, 501-524. 
13. Nigudkar, S. S.; Demchenko, A. V. Stereocontrolled 1,2-cis glycosylation as the 
driving force of progress in synthetic carbohydrate chemistry. Chem. Sci. 2015, 6, 2687-
2704. 
14. Gold, H.; Boot, R. G.; Aerts, J. M. F. G.; Overkleeft, H. S.; Codee, J. D. C.; van 
der Marel, G. A. A concise synthesis of globotriaosylsphingosine. Eur. J. Org. Chem. 
2011, 1652-1663. 
15. Di Brisco, R.; Ronchetti, F.; Mangoni, A.; Costantino, V.; Compostella, F. 
Development of a fluorescent probe for the study of the sponge-derived simplexide 
immunological properties. Carbohydr. Res. 2012, 348, 27-32. 
16. Sarkar, V.; Mukhopadhyay, B. Chemical synthesis of the tetrasaccharide 
repeating unit of the O-polysaccharide isolated from Azospirillum brasilense SR80. 
Carbohydr. Res. 2015, 406, 65-70. 
17. Tzianabos, A. O.; Pantosti, A.; Baumann, H.; Brisson, J. R.; Jennings, H. J.; 
Kasper, D. L. The capsular polysaccharide of Bacteroides fragilis comprises two ionically 
linked polysaccharides. J. Biol. Chem. 1992, 267, 18230-18235. 
18. Martin, C. E.; Broecker, F.; Eller, S.; Oberli, M. A.; Anish, C.; Pereira, C. L.; 
Seeberger, P. H. Glycan arrays containing synthetic Clostridium difficile lipoteichoic 





19. Wang, Z.; Chinoy, Z. S.; Ambre, S. G.; Peng, W.; McBride, R.; de Vries, R. P.; 
Glushka, J.; Paulson, J. C.; Boons, G.-J. A general strategy for the chemoenzymatic 
synthesis of asymmetrically branched N-glycans. Science 2013, 341, 379-383. 
20. Yasomanee, J. P.; Demchenko, A. V. Effect of remote picolinyl and picoloyl 
substituents on the stereoselectivity of chemical glycosylation. J. Am. Chem. Soc. 2012, 
134, 20097-20102. 
21. Liu, Q.-W.; Bin, H.-C.; Yang, J.-S. beta-Arabinofuranosylation using 5-O-(2-
quinolinecarbonyl) substituted ethyl thioglycoside donors. Org. Lett. 2013, 15, 3974-
3977. 
22. Imamura, A.; Ando, H.; Korogi, S.; Tanabe, G.; Muraoka, O.; Ishida, H.; Kiso, 
M. Di-tert-butylsilylene (DTBS) group-directed alpha-selective galactosylation 
unaffected by C-2 participating functionalities. Tetrahedron Lett. 2003, 44, 6725-6728. 
23. Huang, M.; Garrett, G. E.; Birlirakis, N.; Bohe, L.; Pratt, D. A.; Crich, D. 
Dissecting the mechanisms of a class of chemical glycosylation using primary C-13 
kinetic isotope effects. Nat. Chem. 2012, 4, 663-667. 
24. Hashimoto, S.; Hayashi, M.; Noyori, R. Glycosylation using glucopyranosyl 
fluorides and silicon-based catalysts. Solvent dependency of the stereoselection. 
Tetrahedron Lett. 1984, 25, 1379-1382. 
25. Demchenko, A.; Stauch, T.; Boons, G. J. Solvent and other effects on the 
stereoselectivity of thioglycoside glycosidations. Synlett 1997, 818-&. 
26. Meng, B.; Zhu, Z. Q.; Baker, D. C. 1,2-cis Alkyl glycosides: straightforward 





27. Koenigs, W.; Knorr, E. Ueber einige derivate des traubenzuckers und der 
galactose. Ber. Dtsch. Chem. Ges. 1901, 34, 957−981. 
28. Lemieux, R. U.; Driguez, H. Chemical synthesis of 2-acetamido-2-deoxy-4-O-
(.alpha.-L-fucopyranosyl)-3-O-(.beta.-D-galactopyranosyl)-D-glucose. Lewis A blood-
group antigenic determinant. J. Am. Chem. Soc. 1975, 97, 4063-4069. 
29. Lemieux, R. U.; Hendriks, K. B.; Stick, R. V.; James, K. Halide ion catalyzed 
glycosidation reactions. Syntheses of .alpha.-linked disaccharides. J. Am. Chem. Soc. 
1975, 97, 4056-4062. 
30. Sato, S.; Mori, M.; Ito, Y.; Ogawa, T. An efficient approach to O-glycosides 
through CuBr2-Bu4NBr mediated activation of glycosides. Carbohydr. Res. 1986, 155, 
C6-C10. 
31. Andersson, F.; Fugedi, P.; Garegg, P. J.; Nashed, M. Synthesis of 1,2-cis-linked 
glycosides using dimethyl(methylthio) sulfonium triplate as promoter and thioglycosides 
as glycosyl donors. Tetrahedron Lett. 1986, 27, 3919-3922. 
32. Koenigs, W.; Knorr, E. Ueber einige derivate des traubenzuckers und der 
galactose. Ber. Dtsch. Chem. Ges. 1901, 34, 957-981. 
33. Hadd, M. J.; Gervay, J. Glycosyl iodides are highly efficient donors under neutral 
conditions. Carbohydr. Res. 1999, 320, 61-69. 
34. Miquel, N.; Vignando, S.; Russo, G.; Lay, L. Efficient synthesis of O-, S-, N- and 





35. van Well, R. M.; Kartha, K. P. R.; Field, R. A. Iodine promoted glycosylation 
with glycosyl iodides: Alpha-glycoside synthesis. J. Carbohydr. Chem. 2005, 24, 463-
474. 
36. Dabideen, D. R.; Gervay-Hague, J. Unique reactions of glycosyl iodides with oxa- 
and thiocycloalkane acceptors. Org. Lett. 2004, 6, 973-975. 
37. Davis, R. A.; Lin, C.-H.; Gervay-Hague, J. Chemoenzymatic synthesis of 
cholesteryl-6-O-tetradecanoyl-alpha-D-glucopyranoside: A product of host cholesterol 
efflux promoted by Helicobacter pylori. Chem. Commun. 2012, 48, 9083-9085. 
38. Lam, S. N.; Gervay-Hague, J. Glycal scavenging in the synthesis of disaccharides 
using mannosyl iodide donors. J. Org. Chem. 2005, 70, 2387-2390. 
39. Davis, R. A.; Fettinger, J. C.; Gervay-Hague, J. Tandem glycosyl iodide 
glycosylation and regioselective enzymatic acylation affords 6-O-tetradecanoyl-alpha-D-
cholesterylglycosides. J. Org. Chem. 2014, 79, 8447-8452. 
40. Pougny, J. R.; Sinay, P. Reaction d'imidates de glucopyranosyle avec 
l'acetonitrile. Applications synthetiques. Tetrahedron Lett. 1976, 17, 4073-4076. 
41. Pougny, J. R.; Jacquinet, J. C.; Nassr, M.; Duchet, D.; Milat, M. L.; Sinay, P. A 
novel synthesis of 1,2-cis-disaccharides. J. Am. Chem. Soc. 1977, 99, 6762-6763. 
42. Jacquinet, J. C.; Sinay, P. Synthese des substances de groupe sanguin—IX: Une 
synthese du 2-O-(α-l-fucopyranosyl)-3-O-(α-D-galactopyranosyl)-D-galactose, le 
determinant antigenique du groupe sanguin b. Tetrahedron 1979, 35, 365-371. 
43. a) Schmidt, R. R.; Michel, J. Facile synthesis of α- and β-O-glycosyl imidates; 




Schmidt, R. R.; Kinzy, W.; Anomeric-oxygen activation for glycoside synthesis: The 
trichloroacetamidate method. Adv. Carbohydr. Chem. Biochem. 1994, 50, 21-123. 
44. Demchenko, A. Handbook of Chemical Glycosylation. Wiley-VCH Verlag GmbH 
& Co. KGaA: Weinheim, GER, 2008. 
45. Yu, B.; Zhu, X. M.; Hui, Y. Z. 6-S-Phenyl-glycopyranosides as ready precursors 
to the synthesis of glycuronides. Tetrahedron 2001, 57, 9403-9413. 
46. Adinolfi, M.; Barone, G.; Iadonisi, A.; Schiattarella, M. Iodine/triethylsilane as a 
convenient promoter system for the activation of disarmed glycosyl trichloro- and N-
(phenyl)trifluoroacetimidates. Synlett 2002, 269-270. 
47. Schmidt, R. R.; Gaden, H.; Jatzke, H. New catalysts for the glycosyl transfer with 
O-glycosyl trichloroacetimidates. Tetrahedron Lett. 1990, 31, 327-329. 
48. Adinolfi, M.; Barone, G.; Guariniello, L.; Iadonisi, A. Efficient activation of 
armed glycosyl trichloroacetimidates with Sm(OTf)3 in the stereoselective glycosidation 
of saccharidic acceptors. Tetrahedron Lett. 2000, 41, 9005-9008. 
49. Adinolfi, M.; Barone, G.; Iadonisi, A.; Mangoni, L.; Schiattarella, M. Activation 
of disarmed 2-O-alkoxycarbonylated glycosyl trichloroacetimidates with lanthanide 
triflates: an efficient approach for the synthesis of 1,2-trans glycosides. Tetrahedron Lett. 
2001, 42, 5967-5969. 
50. Adinolfi, M.; Iadonisi, A.; Ravida, A.; Valerio, S. Remarkably efficient activation 
of glycosyl trichloro- and (N-phenyl)trifluoroacetimidates with bismuth(III) triflate. 




51. Jona, H.; Mandai, H.; Mukaiyama, T. A catalytic and stereoselective 
glycosylation with glucopyranosyl fluoride by using various protic acids. Chem. Lett. 
2001, 426-427. 
52. Miura, T.; Inazu, T. Rapid synthesis of oligosaccharide moieties of 
globotriaosylceramide using fluorous protective group. Tetrahedron Lett. 2003, 44, 1819-
1821. 
53. Zhao, Y.-t.; Niu, S.; Huang, L.-b.; Wang, J.-m.; Yin, Z.-j.; Li, Q.; Li, Z.-j. 
Synthesis of raffinose family oligosaccharides by regioselective de-O-benzylation with 
Co2(CO)8/Et3SiH/CO system. Tetrahedron 2013, 69, 5022-5028. 
54. Meloncelli, P. J.; Williams, T. M.; Hartmann, P. E.; Stick, R. V. The synthesis of 
2-, 3-, 4- and 6-O-alpha-D-glucopyranosyl-D-galactopyranose, and their evaluation as 
nutritional supplements for pre-term infants. Carbohydr. Res. 2007, 342, 1793-1804. 
55. Tanaka, S.; Takashina, M.; Tokimoto, H.; Fujimoto, Y.; Tanaka, K.; Fukase, K. 
Highly beta-selective mannosylation towards Man beta 1-4GlcNAc synthesis: 
TMSB(C6F5)4 as a Lewis acid/cation trap catalyst. Synlett 2005, 2325-2328. 
56. Hashimoto, S.; Honda, T.; Ikegami, S. A rapid and efficient synthesis of 1,2-
trans-β-linked glycosides via benzyl- or benzoyl-protected glycopyranosyl phosphates. J. 
Chem. Soc. Chem. Comm. 1989, 685-687. 
57. Vankayalapati, H.; Jiang, S. D.; Singh, G. Glycosylation based on glycosyl 
phosphates as glycosyl donors. Synlett 2002, 16-25. 
58. Palmacci, E. R.; Plante, O. J.; Seeberger, P. H. Oligosaccharide synthesis in 





59. Nambu, H.; Nakamura, S.; Suzuki, N.; Hashimoto, S. Stereocontrolled 
construction of 1,2-cis-alpha-glycosidic linkages using glycosyl diphenyl phosphates and 
synthesis of alpha-galactosylceramide KRN7000. Trends Glycosci. Glyc. 2010, 22, 26-
40. 
60. Koshiba, M.; Suzuki, N.; Arihara, R.; Tsuda, T.; Nambu, H.; Nakamura, S.; 
Hashimoto, S. Catalytic stereoselective glycosidation with glycosyl diphenyl phosphates: 
Rapid construction of 1,2-cis-alpha-glycosidic linkages. Chem.-Asian J. 2008, 3, 1664-
1677. 
61. Igarashi, K.; Honma, T.; Irisawa, J. Reaction of glycosyl chlorides with silver 
perchlorate. Carbohydr. Res. 1970, 15, 329-337. 
62. Igarashi, K.; Irisawa, J.; Honma, T. The mechanism of, and the solvent effects in, 
the glycosidation of D-glucosyl chlorides having a non-participating group at C-2, using 
silver perchlorate as catalyst. Carbohydr. Res. 1975, 39, 213-225. 
63. Tanaka, H.; Sakamoto, H.; Sano, A.; Nakamura, S.; Nakajima, M.; Hashimoto, S. 
An extremely mild and stereocontrolled construction of 1,2-cis-alpha-glycosidic linkages 
via benzyl-protected glycopyranosyl diethyl phosphites. Chem. Commun. 1999, 1259-
1260. 
64. Fischer, E.; Delbruck, K. Über thiophenol-glucoside. Ber. Dtsch. Chem. Ges. 
1909, 42, 1476-1482. 
65. Kajimoto, T.; Ishioka, Y.; Katoh, T.; Node, M. Odorless benzenethiols in 
synthesis of thioglycosides and its application for glycosylation reactions. Bioorg. Med. 




66. Bennett, S.; Vonitzstein, M.; Kiefel, M. J. A simple method for the preparation of 
thioglycosides of N-acetylneuraminic acid. Carbohydr. Res. 1994, 259, 293-299. 
67. Kiefel, M. J.; Beisner, B.; Bennett, S.; Holmes, I. D.; vonItzstein, M. Synthesis 
and biological evaluation of N-acetylneuraminic acid-based rotavirus inhibitors. J. Med. 
Chem. 1996, 39, 1314-1320. 
68. Veeneman, G. H.; Vanleeuwen, S. H.; Vanboom, J. H. Iodonium ion promoted 
reactions at the anomeric centre. II An efficient thioglycoside mediated approach toward 
the formation of 1,2-trans linked glycosides and glycosidic esters. Tetrahedron Lett. 
1990, 31, 1331-1334. 
69. Konradsson, P.; Udodong, U. E.; Fraserreid, B. Iodonium promoted reactions of 
disarmed thioglycosides. Tetrahedron Lett. 1990, 31, 4313-4316. 
70. Takeuchi, K.; Tamura, T.; Mukaiyama, T. Stereoselective glycosylation of 
thioglycosides promoted by respective combinations of N-iodo- or N-bromosuccinimide 
and trityl tetrakis(pentafluorophenyl)borate. Application to one-pot sequential synthesis 
of trisaccharide. Chem. Lett. 2000, 124-125. 
71. Valerio, S.; Iadonisi, A.; Adinolfi, M.; Ravida, A. Novel approaches for the 
synthesis and activation of thio- and selenoglycoside donors. J. Org. Chem. 2007, 72, 
6097-6106. 
72. Mukherjee, C.; Misra, A. K. Glycosylation and pyranose-furanose isomerization 
of carbohydrates using HClO4-SiO2: Synthesis of oligosaccharides containing 




73. Nicolaou, K. C.; Dolle, R. E.; Papahatjis, D. P.; Randall, J. L. Practical synthesis 
of oligosaccharides. Partial synthesis of avermectin B1a. J. Am. Chem. Soc. 1984, 106, 
4189-4192. 
74. Meijer, A.; Ellervik, U. Interhalogens (ICI/IBr3) and AgOTf in thioglycoside 
activation; Synthesis of bislactam analogues of ganglioside GD3. J. Org. Chem. 2004, 69, 
6249-6256. 
75. Mukhopadhyay, B.; Cura, P.; Kartha, K. P. R.; Botting, C. H.; Field, R. A. 
Glycosylation with in situ separation: Carbohydrate chemistry on a TLC plate. Org. 
Biomol. Chem. 2005, 3, 3468-3470. 
76. Tsukamoto, H.; Kondo, Y. 1-Fluoropyridinium triflates: versatile reagents for 
transformation of thioglycoside into O-glycoside, glycosyl azide and sulfoxide. 
Tetrahedron Lett. 2003, 44, 5247-5249. 
77. Bohe, L.; Crich, D. A propos of glycosyl cations and the mechanism of chemical 
glycosylation. C. R. Chim. 2011, 14, 3-16. 
78. Dasgupta, F.; Garegg, P. J. Use of the methylsulfenyl cation as an activator for 
glycosylation reactions with alkyl (aryl) l-thioglycopyranosides: synthesis of methyl O-
(2-acetamido-2-deoxy-β-D-glucopyranosyl)-(1→2)-α-d-glucopyranoside, a derivative of 
the core trisaccharide of E. coli K12. Carbohydr. Res. 1990, 202, 225-238. 
79. Martichonok, V.; Whitesides, G. M. Stereoselective alpha-sialylation with sialyl 
xanthate and phenylsulfenyl triflate as a promotor. J. Org. Chem. 1996, 61, 1702-1706. 
80. Geng, Y.; Zhang, L.-H.; Ye, X.-S. Stereo selectivity investigation on 
glycosylation of oxazolidinone protected 2-amino-2-deoxy-D-glucose donors based on 




81. Crich, D.; Li, H. M. Synthesis of the salmonella type E-1 core trisaccharide as a 
probe for the generality of 1-(benzenesulfinyl)piperidine/triflic anhydride combination 
for glycosidic bond formation from thioglycosides. J. Org. Chem. 2002, 67, 4640-4646. 
82. Crich, D.; Li, W. Efficient glycosidation of a phenyl thiosialoside donor with 
diphenyl sulfoxide and triflic anhydride in dichloromethane. Org. Lett. 2006, 8, 959-962. 
83. Tatai, J.; Fugedi, P. A new, powerful glycosylation method: Activation of 
thioglycosides with dimethyl disulfide-triflic anhydride. Org. Lett. 2007, 9, 4647-4650. 
84. Kartha, K. P. R.; Aloui, M.; Field, R. A. Iodine: A versatile reagent in 
carbohydrate chemistry II. Efficient chemospecific activation of thiomethylglycosides. 
Tetrahedron Lett. 1996, 37, 5175-5178. 
85. Wang, C.; Wang, H.; Huang, X.; Zhang, L.-H.; Ye, X.-S. Benzenesulfinyl 
morpholine: A new promoter for one-pot oligosaccharide synthesis using thioglycosides 
by pre-activation strategy. Synlett 2006, 2846-2850. 
86. Nakanishi, M.; Takahashi, D.; Toshima, K. Light-induced O-glycosylation of 
unprotected deoxythioglycosyl donors. Org. Biomol. Chem. 2013, 11, 5079-5082. 
87. Chu, A.-H. A.; Son Hong, N.; Sisel, J. A.; Minciunescu, A.; Bennett, C. S. 
Selective synthesis of 1,2-cis-alpha-glycosides without directing groups. Application to 
iterative oligosaccharide synthesis. Org. Lett. 2013, 15, 2566-2569. 
88. Demchenko, A. V.; Malysheva, N. N.; De Meo, C. S-Benzoxazolyl (SBox) 
glycosides as novel, versatile glycosyl donors for stereoselective 1,2-cis glycosylation. 
Org. Lett. 2003, 5, 455-458. 
89. Parameswar, A. R.; Pornsuriyasak, P.; Lubanowski, N. A.; Demchenko, A. V. 




serotypes 6A and 6B containing multiple 1,2-cis glycosidic linkages. Tetrahedron 2007, 
63, 10083-10091. 
90. Ranade, S. C.; Hasty, S. J.; Demchenko, A. V. A comparative study of glycosyl 
thioimidates as building blocks for chemical glycosylation. J. Carbohydr. Chem. 2013, 
32, 360-379. 
91. Tatsumi, S.; Matsumura, F.; Oka, N.; Wada, T. Glycosylation of alcohols using 
glycosyl boranophosphates as glycosyl donors. Tetrahedron Lett. 2013, 54, 3731-3734. 
92. Wu, Z. C.; Kong, F. Z. Synthesis of 6-branched cyclo-(1→3)-glucohexaose and 
glucooctaose. Synlett 2004, 2594-2596.  
93. Zhang, G. H.; Fu, M. K.; Ning, J. Synthesis of galactose-containing analogues of 
(1→6)-branched (1→3)-glucohexaose and its lauryl glycoside. Carbohydr. Res. 2005, 
340, 597-602. 
94. Khodair, A. I.; Winterfeld, G. A.; Schmidt, R. R. Conjugate addition of phenols to 
2-nitrogalactal; Synthesis of O-(2-acetamido-2-deoxygalactosyl)tyrosine. Eur. J. Org. 
Chem. 2003, 1847-1852. 
95. Kuroiwa, Y.; Sekine, M.; Tomono, S.; Takahashi, D.; Toshima, K. A novel 
glycosylation of inactive glycosyl donors using an ionic liquid containing a protic acid 
under reduced pressure conditions. Tetrahedron Lett. 2010, 51, 6294-6297. 
96. Kim, K. S.; Kim, J. H.; Lee, Y. J.; Park, J. 2-(Hydroxycarbonyl)benzyl 
glycosides: A novel type of glycosyl donors for highly efficient beta-
mannopyranosylation and oligosaccharide synthesis by latent-active glycosylation. J. Am. 




97. Kwon, Y. T.; Lee, Y. J.; Lee, K.; Kim, K. S. Synthesis of the trisaccharide 
repeating unit of the atypical O-antigen polysaccharide from Danish Helicobacter pylori 
strains employing the 2'-carboxybenzyl glycoside. Org. Lett. 2004, 6, 3901-3904. 
98. Kim, J.-H.; Yang, H.; Khot, V.; Whitfield, D.; Boons, G.-J. Stereoselective 
glycosylations using (R)- or (S)-(ethoxycarbonyl)benzyl chiral auxiliaries at C-2 of 
glycopyranosyl donors. Eur. J. Org. Chem. 2006, 5007-5028. 
99. Fang, T.; Mo, K.-F.; Boons, G.-J. Stereoselective assembly of complex 
oligosaccharides using anomeric sulfonium ions as glycosyl donors. J. Am Chem Soc. 
2012, 134, 7545-7552. 
100. Baek, J. Y.; Lee, B.-Y.; Jo, M. G.; Kim, K. S. beta-Directing effect of electron-
withdrawing groups at O-3, O-4, and O-6 positions and alpha-directing effect by remote 
participation of 3-O-acyl and 6-O-acetyl groups of donors in mannopyranosylations. J. 
Am. Chem. Soc. 2009, 131, 17705-17713. 
101. Ishikawa, T.; Fletcher, H. G. Synthesis and solvolysis of some D-glucopyranosyl 
bromides having a benzyl group at C-2. J. Org. Chem. 1969, 34, 563-571. 
102. Smoot, J. T.; Pornsuriyasak, P.; Demchenko, A. V. Development of an arming 
participating group for stereoselective glycosylation and chemoselective oligosaccharide 
synthesis. Angew. Chem. Int. Ed. 2005, 44, 7123-7126. 
103. Pistorio, S. G.; Yasomanee, J. P.; Demchenko, A. V. Hydrogen-bond-mediated 
aglycone delivery: Focus on beta-mannosylation. Org. Lett. 2014, 16, 716-719. 
104. Komarova, B. S.; Orekhova, M. V.; Tsvetkov, Y. E.; Nifantiev, N. E. Is an acyl 




The role of conformational mobility and the protecting group at O-6. Carbohydr. Res. 
2014, 384, 70-86. 
105. Vanboeckel, C. A. A.; Beetz, T.; Vanaelst, S. F. Substituent effects on 
carbohydrate coupling reactions promoted by insoluble silver salts. Tetrahedron 1984, 
40, 4097-4107. 
106. Kalikanda, J.; Li, Z. Study of the stereoselectivity of 2-azido-2-deoxygalactosyl 
donors: Remote protecting group effects and temperature dependency. J. Org. Chem. 
2011, 76, 5207-5218. 
107. Crich, D.; Cai, W. L.; Dai, Z. M. Highly diastereoselective alpha-
mannopyranosylation in the absence of participating protecting groups. J. Org. Chem. 
2000, 65, 1291-1297. 
108. Walvoort, M. T. C.; Lodder, G.; Mazurek, J.; Overkleeft, H. S.; Codee, J. D. C.; 
van der Marel, G. A. Equatorial anomeric triflates from mannuronic acid esters. J. Am. 
Chem. Soc. 2009, 131, 12080-12081. 
109. Walvoort, M. T. C.; Lodder, G.; Overkleeft, H. S.; Codee, J. D. C.; van der Marel, 
G. A. Mannosazide methyl uronate donors. Glycosylating properties and use in the 
construction of beta-ManNAcA-containing oligosaccharides. J. Org. Chem. 2010, 75, 
7990-8002. 
110. Fraserreid, B.; Wu, Z. F.; Andrews, C. W.; Skowronski, E.; Bowen, J. P. 
Torsional effects in glycoside reactivity: Saccharide couplings mediated by acetal 




111. Crich, D.; Jayalath, P.; Hutton, T. K. Enhanced diastereoselectivity in beta-
mannopyranosylation through the use of sterically minimal propargyl ether protecting 
groups. J. Org. Chem. 2006, 71, 3064-3070. 
112. Codee, J. D. C.; Hossain, L. H.; Seeberger, P. H. Efficient installation of beta-
mannosides using a dehydrative coupling strategy. Org. Lett. 2005, 7, 3251-3254. 
113. Baek, J. Y.; Choi, T. J.; Jeon, H. B.; Kim, K. S. A highly reactive and 
stereoselective beta-mannopyranosylation system: Mannosyl 4-pentenoate/PhSeOTf. 
Angew. Chem. Int. Ed. 2006, 45, 7436-7440. 
114. El Ashry, E. S. H.; Rashed, N.; Ibrahim, E. S. I. Strategies of synthetic 
methodologies for constructing beta-mannosidic linkage. Curr. Org. Synth. 2005, 2, 175-
213. 
115. Crich, D.; Sun, S. X. Formation of beta-mannopyranosides of primary alcohols 
using the sulfoxide method. J. Org. Chem. 1996, 61, 4506-4507. 
116. Weingart, R.; Schmidt, R. R. Can preferential beta-mannopyranoside formation 
with 4,6-O-benzylidene protected mannopyranosyl sulfoxides be reached with 
trichloroacetimidates? Tetrahedron Lett. 2000, 41, 8753-8758. 
117. Nagai, H.; Matsumura, S.; Toshima, K. Environmentally benign and 
stereoselective formation of beta-mannosidic linkages utilizing 2,3-di-O-benzyl-4,6-O-
benzylidene-protected mannopyranosyl phosphite and montmorillonite K-10. Carbohydr. 
Res. 2003, 338, 1531-1534. 
118. El-Badri, M. H.; Willenbring, D.; Tantillo, D. J.; Gervay-Hague, J. Mechanistic 
studies on the stereoselective formation of beta-mannosides from mannosyl iodides using 




119. Kim, K. S.; Lee, Y. J.; Kim, H. Y.; Kang, S. S.; Kwon, S. Y. Glycosylation with 
glycosyl benzyl phthalates as a new type of glycosyl donor. Org. Biomol. Chem. 2004, 2, 
2408-2410. 
120. Crich, D.; Vinogradova, O. On the influence of the C2-O2 and C3-O3 bonds in 
4,6-O-benzylidene-directed beta-mannopyranosylation and alpha-glucopyranosylation. J. 
Org. Chem. 2006, 71, 8473-8480. 
121. Crich, D.; Li, L. 4,6-O-Benzylidene-directed beta-mannopyranosylation and 
alpha-glucopyranosylation: The 2-deoxy-2-fluoro and 3-deoxy-3-fluoro series of donors 
and the importance of the O2-C2-C3-O3 interaction. J. Org. Chem. 2007, 72, 1681-1690. 
122. Crich, D.; Cai, W. L. Chemistry of 4,6-O-benzylidene-D-glycopyranosyl triflates: 
Contrasting behavior between the gluco and manno series. J. Org. Chem. 1999, 64, 4926-
4930. 
123. Crich, D.; Chandrasekera, N. S. Mechanism of 4,6-O-benzylidene-directed beta-
mannosylation as determined by alpha-deuterium kinetic isotope effects. Angew. Chem. 
Int. Ed. 2004, 43, 5386-5389. 
124. Zhu, T.; Boons, G. J. Thioglycosides protected as trans-2,3-cyclic carbonates in 
chemoselective glycosylations. Org. Lett. 2001, 3, 4201-4203. 
125. Crich, D.; Jayalath, P. Stereocontrolled formation of beta-glucosides and related 
linkages in the absence of neighboring group participation: Influence of a trans-fused 2,3-
O-carbonate group. J. Org. Chem. 2005, 70, 7252-7259. 
126. Geng, Y.; Qin, Q.; Ye, X.-S. Lewis acids as alpha-directing additives in 
glycosylations by using 2,3-O-carbonate-protected glucose and galactose thioglycoside 




127. Benakli, K.; Zha, C. X.; Kerns, R. J. Oxazolidinone protected 2-amino-2-deoxy-
D-glucose derivatives as versatile intermediates in stereoselective oligosaccharide 
synthesis and the formation of alpha-linked glycosides. J. Am. Chem. Soc. 2001, 123, 
12933-12933. 
128. Wei, P.; Kerns, R. J. Factors affecting stereocontrol during glycosidation of 2,3-
oxazolidinone-protected 1-tolylthio-N-acetyl-D-glucosamine. J. Org. Chem. 2005, 70, 
4195-4198. 
129. Satoh, H.; Manabe, S.; Ito, Y.; Luethi, H. P.; Laino, T.; Hutter, J. Endocyclic 
cleavage in glycosides with 2,3-trans cyclic protecting groups. J. Am. Chem. Soc. 2011, 
133, 5610-5619. 
130. Manabe, S.; Ishii, K.; Ito, Y. N-Benzyl-2,3-trans-carbamate-bearing glycosyl 
donors for 1,2-cis-selective glycosylation reactions. Eur. J. Org. Chem. 2011, 497-516. 
131. Imamura, A.; Ando, H.; Ishida, H.; Kiso, M. Di-tert-butylsilylene-directed alpha-
selective synthesis of 4-methylumbelliferyl T-antigen. Org. Lett. 2005, 7, 4415-4418. 
132. Imamura, A.; Kimura, A.; Ando, H.; Ishida, H.; Kiso, M. Extended applications 
of di-tert-butylsilylene-directed alpha-predominant galactosylation compatible with C2-
participating groups toward the assembly of various glycosides. Chem. Eur. J. 2006, 12, 
8862-8870. 
133. Imamura, A.; Ando, H.; Ishida, H.; Kiso, M. DTBS Effect: The unique sterically 
driven director for α-galactosylation. Heterocycles 2008, 76, 883-908. 
134. Oscarson, S.; Sehgelmeble, F. W. A novel beta-directing fructofuranosyl donor 




135. Miljkovic, M.; Yeagley, D.; Deslongchamps, P.; Dory, Y. L. Experimental and 
theoretical evidence of through-space electrostatic stabilization of the incipient 
oxocarbenium ion by an axially oriented electronegative substituent during 
glycopyranoside acetolysis. J. Org. Chem. 1997, 62, 7597-7604. 
136. Zhu, X.; Kawatkar, S.; Rao, Y.; Boons, G.-J. Practical approach for the 
stereoselective introduction of beta-arabinofuranosides. J. Am. Chem. Soc. 2006, 128, 
11948-11957. 
137. Joe, M.; Bai, Y.; Nacario, R. C.; Lowary, T. L. Synthesis of the 
docosanasaccharide arabinan domain of mycobacterial arabinogalactan and a proposed 
octadecasaccharide biosynthetic precursor. J. Am. Chem. Soc. 2007, 129, 9885-9901. 
138. Fischer, E. Ueber die glucoside der alkohole. Ber. Dtsch. Chem. Ges. 1893, 26, 
2400-2412. 
139. Guchhait, G.; Misra, A. K. Efficient glycosylation of unprotected sugars using 
sulfamic acid: A mild eco-friendly catalyst. Catal. Commun. 2011, 14, 52-57. 
140. Bornaghi, L. F.; Poulsen, S. A. Microwave-accelerated Fischer glycosylation. 
Tetrahedron Lett. 2005, 46, 3485-3488. 
141. Shaikh, N.; Russo, L.; Cipolla, L.; Nicotra, F. Ultrasonic assisted Fischer 
glycosylation: generating diversity for glycochemistry. Mol. Diversity 2011, 15, 341-345. 
142. Hanessian, S.; Lu, P. P.; Ishida, H. One-step, stereocontrolled synthesis of 
glycosyl 1-phosphates, uridine-5'-diphosphogalactose, and uridine-5'-diphosphoglucose 
from unprotected glycosyl donors. J. Am. Chem. Soc. 1998, 120, 13296-13300. 
143. Mamidyala, S. K.; Finn, M. G. Glycosylation using unprotected alkynyl donors. J. 




144. Hasty, S. J.; Kleine, M. A.; Demchenko, A. V. S-Benzimidazolyl glycosides as a 
platform for oligosaccharide synthesis by an acitve-latent strategy. Angew. Chem. Int. Ed. 
2011, 50, 4197-4201. 
145. Nguyen, S. H.; Trotta, A. H.; Cao, J.; Straub, T. J.; Bennett, C. S. Direct O-














































Chapter 2 1,2-cis Alkyl Glycosides: Straightforward 




















A 1,2-cis-alkyl glycosidation protocol that makes use of unprotected phenyl 1-
thioglycosyl donors is reported. Glycosylation of various functionalized alcohols was 
accomplished in moderate to high yield and selectivity to give the 1,2-cis-glycosides. In 
order to quickly develop optimum glycosylation conditions, an FIA (flow injection 
analysis)–ESI-TOF-MS method was developed that enabled rapid and quantitative 
evaluation of yield on small scale. This methodology, coupled with NMR spectroscopy, 




















As essential components in the cell membrane, carbohydrates and 
glycoconjugates serve many protective, stabilizing, organizational, barrier, and 
recognition functions.
1
 The chemical synthesis of these glycoconjugates, including 
proteoglycans, glycolipids, and glycoproteins, is in great demand for biological studies of 
their functions as cell-wall components that are collectively termed the glycocalyx. 
Anomerically pure alkyl glycosides serving as fundamental building blocks are in 
demand to achieve the stereoselective synthesis of these cell-wall structures. Some alkyl 










Generally, 1,2-trans-alkyl glycosidation can be reliably achieved via neighboring-
group participation of a C-2 acyl group on a glycosyl donor, while stereochemical control 
for 1,2-cis-alkyl glycosidation can be challenging.
7
 The conventional Fischer 
glycosidation reaction, a straightforward way to afford short-chain, uncomplicated, 












free sugars have limited solubility in longer-chain alcohols (acceptors), harsh conditions 
(e.g., high temperature, microwave, ultrasonication) are often required to push the 
reaction, which results in decomposition of the products,
8
 formation of various side 
products, time-consuming separation processes, and low yields and poor 
stereoselectivities. Ether protecting groups, most often the benzyl group, are routinely 
used for protecting free hydroxyl groups in the synthesis of 1,2-cis-glycosides,
14
 but 




halogen) on functionalized alkyl glycosides.
15
 The elegant intramolecular aglycon 




 In principle, many of these issues can be circumvented through conversion of an 
unprotected glycosyl donor directly into the desired 1,2-cis alkyl glycosides. 
Glycosylation by an unprotected sugar donor has several practical values:
20
 the often 
tedious protection and deprotection process can be avoided;
21
 unprotected donors possess 
higher reactivity compared to O-acyl-protected donors, and the better solubility of 
unprotected donors in short-chain alcohols (acceptors) enables glycosylation at lower 
temperatures, which reduces the formation of by-products.  
 Mamidyala and Finn have reported glycosylation using unprotected alkynyl 
donors and AuCl3 as an effective activator.
22, 23
 Very recently, Nitz and co-workers 
reported glycosidation in relatively good yields using a protecting-group-free protocol 
with 1-p-toluenesulfonyl hydrazide and glycosyl chloride donors; however, anomeric 
selectivities were generally lacking.
24
 Among the various classes of glycosyl donors, 
phenyl 1-thioglycosyl compounds have been regarded as ideal choices for donor 
precursors (including precursors for light-induced glycosidation
21
) because they are 
stable, easily synthesized, and for the most part, crystalline.
25
 Herein, I report a 1,2-cis-




2.2 Glycosidations  
 Phenyl 1-thio-β-D-galactopyranoside (1a)
26
 and propargyl alcohol (2a) were 




glycosylation reaction (Table 2.1). Initially, the reaction was carried out between 1a and 
dry 2a (40 equiv) under the activation of N-iodosuccinimide (NIS)/trimethylsilyl triflate 
(TMSOTf). The desired product was obtained in respectable yield and stereoselectivity 
(Table 2.1, entry 1). TLC analysis of the crude product showed only the desired α,β 





used for 1,2-cis-glycosidations, provided similar yields and stereoselectivities, while 
H2SO4·SiO2
9
 gave a lower yield (a result also reported from another laboratory
28
) but 
higher stereoselectivity (entries 2−4). I surmise that the results may be due to the 
heterogeneity of the H2SO4·SiO2 catalyst. The bisulfate counterion would be trapped in 
the silica gel matrix, leading to the formation of a loosely solvent-separated ion pair 
(SSIP) between the bisulfate counterion and the oxocarbenium ion, suggesting a 
unimolecular (SN1) favored transition state and better α selectivity due to the anomeric 
effect.
29–31
 I also examined the activation by Lewis acids and N-bromosuccinimide 
(NBS). As anticipated, relatively lower yields and stereoselectivities were observed 
(entries 5 and 6), which could be attributed to the diminished electrophilic properties of 
the bromonium ion. Moreover, experimentation showed that glycosylation was most 
favored when the amount of alcohol was in the range of 40–60 equiv (entries 1–3 and 9 
vs. entries 7–8 and 10). Experiments further demonstrated neither TMSOTf nor NIS 
alone was able to trigger the glycosylation reaction (entries 11 and 12).  
2.3 Rapid High-Throughput Screening of Reactions 
 In order to rapidly evaluate and optimize glycosylation conditions for a number of 
reactions, I adapted the concept of high-throughput screening using mass spectrometry 

























1 TMSOTf NIS 40 75 10:1 
2 BF3∙OEt2 NIS 40 74 10:1 
3 TfOH NIS 40 76 9:1 
4 H2SO4∙SiO2 NIS 40 52 15:1 
5 TMSOTf NBS 40 59 5:1 
6 BF3∙OEt2 NBS 40 38 5:1 
7 TMOSTf NIS 20 50 7:1 
8 TMSOTf NIS 30 53 10:1 
9 TMSOTf NIS 60 76 10:1 
10 TMSOTf NIS 100 58 11:1 
11 TMSOTf None 40 0 - 
12 None NIS 40 0 - 
 
a
The reaction was conducted using 0.37 mmol of 1a, 1.03 mmol of NIS/NBS, and 
0.07 mmol of Lewis acid. 
b
The yield was determined after acetylation by FIA–ESI-TOF-
MS. 
c
The anomeric ratio was determined by integration of H-1 in the 
1
H NMR spectrum 








In the reactions with small molecules, I used a coupled flow-injection system with ESI-
TOF-MS (FIA–ESI-TOF-MS) that enabled quantitative evaluation of glycosylation yield 
with products of MW <500 amu. Furthermore, the method provided a more accurate 
estimation of yield in two ways: (1) An average value from a certain volume of sample 
(e.g., 2.5 μL with our flow-injection equipment) was evaluated rather than a tiny spot 
excited by the laser on MALDI. (2) Integration of the ion intensity peaks was used to 
calculate yield instead of the m/z peak height as in  the MALDI method.
32, 33
 
 In order to provide an internal standard for the FIA–ESI-TOF-MS studies, 
propargyl α-D-galactopyranoside (3a, Scheme 2.1) was acetylated with Ac2O-d6 to afford 
the per-deuterated glycoside 4. While it is known that the ionizing properties of 
deuterated and nondeuterated glycosides are nearly identical,
32
 the fact was confirmed in 
this study specifically for these compounds. The FIA–ESI-TOF-MS responses were 




H-labeled compounds, thus facilitating a 
relatively uncomplicated rapid analysis of the reactions. 
 
Scheme 2.1 Synthesis of deuterated glycoside substrate as the internal standard. 
2.3.1 Flow-injection–ESI-TOF-MS (FIA–ESI-TOF-MS) instrumentation 
The QStar Elite mass spectrometer was outfitted with a flow-injection analysis 
(FIA) device to provide rapid and effective injection of multiple samples for ESI-TOF-










Figure 2.1 Flow-injection device outfitted on QStar Elite TOF-MS instrument. A: 
Dionex Ultimate fully integrated micro-, capillary-, and nano-HPLC system (Sunnyvale, 
CA, USA), B: 6-Port manual injection valve (Rheodyne, Rohnert Park, CA), and C: AB 
Sciex QSTAR Elite triple quadrupole time-of-flight (QTOF) mass spectrometer 












• FIA flow 
– Solvent: MeOH 
– Flow rate: 120 μL/min 
• Manual injection 
– Sample concentration: 10 μg/mL; 25 μL diluted to 1.00 mL with MeOH for injection 
– Loop volume: 2.5 μL 
– Syringe size: 250 μL  
– Injections at 2-min intervals; 10 times each 
2.3.2 High-throughput screening/reaction optimization by flow-injection analysis–
ESI-TOF-MS (FIA–ESI-TOF-MS) 
Before the screening for glycosylation conditions, I carefully examined whether 
the ionizing properties of deuterated and nondeuterated glycoside isomers are identical. 
To establish a quantitative calibration curve, deuterium-labeled glycoside solution [10 
μg/mL, propargyl 2,3,4,6-tetra-O-(acetyl-d3)-α-D-galactopyranoside (4)] and non-labeled 
glycoside solution [propargyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4a)] were 
prepared separately, mixed in five concentration ratios, and diluted to the same volume 
by MeOH to afford five standards (Table 2.2). A six-port manual injection valve was 
installed between the LC pump and the ESI-QTOF instrument. MeOH was chosen as the 
FIA solvent. Each sample was injected into the six-port manual injection valve with a 
2.5-μL sample loop and analyzed by ESI-QTOF-MS for 10 replicates. Non-labeled 
glycoside ([MH+Na]
+
 ion) and labeled ([MD+Na]
+










Table 2.2 Comparison of 
[CH]
[CD]














1 0.2 0.2061 0.0095 
2 0.4 0.3955 0.0094 
3 1 0.9946 0.0158 
4 2.5 2.5619 0.0354 
5 5 5.2201 0.4221 
a 
Concentration ratios of non-labeled standards/labeled standards. 
b 













Figure 2.2 ESI-TOF-MS of product 4a ([MH+Na)
+
] ion at m/z 409) and internal standard 
(deuterated) 4 ([MD+Na)
+







Figure 2.3 Relationship between concentration ratios of standards (
[𝐂𝐇]
[𝐂𝐃]





y = 1.0467x - 0.0294 




















421, respectively (Figure 2.2).  Integration of peak areas under extracted peak profiles at 
m/z 409 and m/z 421 were performed, and peak area ratios were calculated for each entry. 
The results indicated that the ionizing properties of the deuterated and nondeuterated 
glycoside isomers are almost identical, which enables quantification of the nondeuterated 
glycoside when deuterated glycoside is added as an internal standard (Figure 2.3). 
For a general analytical method, the internal standard was dissolved in CH2Cl2 to 
afford a 10 μg/mL solution. The crude product (non-labeled glycoside) was also 
dissolved in CH2Cl2 to get an estimated 10 μg/mL solution. Samples (20 μL) of both 
labeled and non-labeled solutions were mixed and diluted with MeOH to get a 1 mL of 
solution. The solution was injected into the six-port injection valve, and the injection was 
repeated 10 times at 2-min intervals. The peaks of labeled ([MD+Na]
+
 ion at m/z 421) and 
non-labeled ([MH+Na]
+
 ion at m/z 409) glycoside were observed (Figure 2.2). After 
analyzing the ratio of the two peak areas, the concentration of the non-labeled glycoside 
solution was obtained. 
2.3.3 Optimization studies and scope of the reaction    
 Optimization studies were conducted as in the following paragraphs in which 
several solvents and solvent mixtures were examined. The conditions were those of Table 
2.1, with variations. The effect of N,N-dimethylformamide (DMF) in the solvent on 
stereoselective α-glycosylation has been well documented,
34
 and I anticipated that adding 
a catalytic amount of DMF might promote the formation of the 1,2-cis-glycosidic bond. 
After screening with added DMF, other solvents, including CH2Cl2, THF and Et2O (0.2 
equiv), were examined; however, no obvious improvement in yield or α selectivity was 




added (6 equiv) led to a decrease in stereoselectivity and yield, which indicates that a neat 
alcohol environment is essential for optimum glycosylation under these conditions.  
With the appropriate conditions for 1,2-cis-alkyl glycosidation in hand, I 
investigated the scope of the reaction with several unprotected glycosyl donors and 
alcohols bearing various functional groups. (See Table 2.3.) The stereoselectivity of 
glycosylation with unprotected D-glucose, D-mannose and disaccharide donors and 
propargyl alcohol spanned from modest to high (Table 2.3, entries 1, 9−12). It is 
noteworthy that the major product from phenyl 1-thio-α-D-mannoside is the β (cis) 
anomer (Table 2.3, entry 10) that is formed. Glycosylation with various functionalized 
alcohols was accomplished without difficulty (Table 2.3, entries 2−8). A variety of 
groups on alcohols were tolerated to provide the corresponding 1,2-cis-substituted-alkyl 
glycosides. These results indicate the generality and applicability of the present 
glycosylation method. 
2.4 Proposed Mechanism   
A mechanistic explanation of the observed results from these glycosylations is no 
doubt complex, as numerous alcohol–substrate–Lewis acid reagent associations 
(including H-bonding interactions) are possible and difficult to sort out. I presume the 
role of NIS/TMSOTf is critical for the activation of related systems.
35, 36
 Perhaps 
noteworthy is the fact (Table 2.3, entry 13) that a 2-deoxy-1-thioglycoside (1f), an analog 
of 1a, gives a significantly diminished α selectivity of only 1.7:1, possibly indicating a 
special role for the 2-OH group that might coordinate with the reagent alcohol and 
account for the generally higher cis-selectivities in the other examples. The role of such 






Table 2.3 Scope of the reaction
a
 
















































































 For details of the synthetic procedures, see the Experimental Section. 
b
 Isolated yield 
after acetylation of the products to give 4a–4m except for 3d. 
c
 The anomeric ratio was 
determined by integrating the 
1
H NMR spectrum of the crude product. 
d
 The reaction was 
performed at −10 °C. 
e
 Isolated yield without acetylation. 
f
 The anomeric ratio was 
determined from isolated products. 
g













A mechanism for the 1,2-cis-glycosylation (Scheme 2.2) is proposed based on the 
analysis above. Upon the activation of the iodonium ion
28
 generated by NIS/TMSOTf, 
the phenyl 1-thioglycoside is converted to an oxocarbenium ion, which traps the triflate 
counterion to form an oxocarbenium–triflate ion pair.
29
 The generally good solubility of 
the unprotected donors in alcohols (acceptors) indicates H-bond formation, one of which 
will coordinate the 2-OH with the oxygen of the alcohol, increasing its nucleophilicity
30
 
and steering the nucleophilic attack for cis selectivity via a five-membered ring transition 
state.  A final deprotonation step achieves the 1,2-cis glycosides, which is in accordance 
with the fact that only catalytic amount of Lewis acid is needed. 
2.5 Experimental Section 
2.5.1 General methods 
All chemicals were purchased as reagent grade and used without further 
purification, unless otherwise noted. Alcohols that were opened and stored for a period of 
time were pre-dried by Drierite
®
 (anhyd calcium sulfate). Reagent grade dichloromethane 
(CH2Cl2), diethyl ether (Et2O), tetrahydrofuran (THF), methanol (MeOH), N,N-
dimethylformamide (DMF) and toluene were obtained from the Pure-Solv (Innovation 
Technologies) solvent system that uses alumina columns except for DMF, which was 
dried over a column of 5 Ǻ molecular sieves. Pyridine was distilled over CaH2 prior to 
use. All reactions were performed under anhydrous conditions unless otherwise noted. 
Reactions were monitored by thin-layer chromatography (TLC) on silica gel precoated 
aluminum plates. Zones were detected by UV irradiation using a 254 nm lamp and/or by 
heat/charring with p-anisaldehyde–sulfuric acid development reagent.
42
 Column 




obtained at the sodium D line using a Perkin–Elmer 241 polarimeter. 
1
H (500 MHz) and 
13
C NMR (125 MHz) spectra were recorded at room temperature with a Varian Inova 500 
MHz instrument. Chemical shifts are reported in δ-units (ppm) relative to the residual 
1
H 
CDCl3 at δ 7.26 ppm and 
13
C at δ 77.16 ppm. All two-dimensional experiments (gCOSY, 
gHSQC and gHMBC) were recorded on the same instrument using Varian protocols. 
Mass spectrometric analysis was performed on a QSTAR Elite quadrupole time-of-flight 
(QTOF) mass spectrometer with an ESI source.  
2.5.2 General synthetic procedures 
(1). Synthesis of the phenyl thioglycoside donors 1a–1f
26
  
The selected free sugar (5.0 g, 27.8 mmol for D-galactose, 1.0 g, 5.6 mmol for D-
glucose, D-mannose and 2-deoxy-D-galactose, and 1.0 g, 2.9 mmol for disaccharide) was 
suspended in a mixture of NaOAc (2.50 g, 30.5 mmol for D-galactose, 0.50 g, 6.1 mmol 
for other sugars) and Ac2O (25 mL, 262.3 mmol for D-galactose, 5 mL, 52.5 mmol for 
other sugars), and the mixture was heated under an N2 atmosphere to 70 °C. After 24 h, 
the yellow solution was cooled to room temperature, poured onto ice and quenched with 
satd aq NaHCO3. The aqueous phase was extracted with CH2Cl2 (3 × 50 mL). The 
organic extract was washed successively with water and brine, dried over anhyd Na2SO4, 
and concentrated to afford the per-acetylated sugar as a solid that was used directly 
without further purification. 
Thiophenol (3.60 mL, 35.2 mmol for the per-acetylated D-galactose; amounts for 
the other sugars were adjusted correspondingly) was then added to a solution of per-
acetylated sugar (10.6 g, 27.1 mmol) in dry CH2Cl2 (20 mL) at 0 °C, and the mixture 




the mixture, which was allowed to warm to room temperature.  After 5 h, the mixture was 
diluted by CH2Cl2, washed with satd aq NaHCO3 and brine, dried over anhyd Na2SO4, 
concentrated in vacuo, and purified by column chromatography (hexanes–EtOAc 5:1, 
hexanes–EtOAc 2.5:1 for the disaccharides) to afford the per-acetylated phenyl 
thioglycoside as a colorless syrup.  
The per-acetylated phenyl thioglycoside (22.5 mmol for per-acetylated phenyl 1-
thio-D-galactoside, amounts for other sugars were reduced correspondingly) was then 
dissolved in dry MeOH (20 mL), followed by the addition of a small amount of NaOMe 
to afford pH 9. After 2 h the solution was quenched by the addition of Amberlite
®
 IR 120 
(H
+
) resin.  The resin was filtered off, and the solvent was removed in vacuo to afford the 
unprotected phenyl thioglycoside donor as a white powdery solid. 
Literature reports for the phenyl thioglycosides 1a–c and 1e are as follows:  
phenyl 1-thio-β-D-galactopyranoside (1a),
26









glucopyranoside (1dβ), a new compound, was prepared as in the foregoing paragraphs 
and is characterized NMR spectroscopy and high-resolution MS in the following 
paragraph. 
 






H NMR (500 MHz, CD3OD): δ 7.56–7.54 (m, 2H), 7.36–7.33 (m, 2H), 7.29–
7.26 (m, 1H), 4.89 (d, J = 3.5 Hz, 1H, H-1’), 4.70 (d, J = 9.8 Hz, 1H, H-1), 3.92 (dd, J = 
10.8, 6.1 Hz, 1H), 3.88 (ddd, J = 6.6, 5.6, 1.4 Hz, 1H), 3.83 (m, 1H), 3.80–3.73 (m, 3H), 
3.70 (m, 2H), 3.59–3.56 (m, 1H), 3.43 (t, J = 8.8 Hz, 1H), 3.37 (m, 1H), 3.27 (dd, J = 9.8, 
8.6 Hz, 1H). 
13
C NMR (125 MHz, CD3OD): δ 135.29, 132.15, 130.01, 128.26, 100.10, 
89.04, 80.29, 79.65, 73.92, 72.11, 71.53, 71.49, 71.12, 70.38, 67.94, 62.84. HRESIMS: 
(m/z) (M+Na)
+
 calcd for C29H38O18Na
+
 457.1144; found 457.1146. 
(2). Glycosylation to give glycosides 3a–3m. 
Phenyl 1-thiogalactoside donor 1a (100 mg, 0.37 mmol) was dissolved in 
propargyl alcohol (2a, 0.87 mL, 0.82 g, 14.71 mmol), followed by the addition of pre-
activated powdered 4 Å molecular sieves (150 mg), and stirring was continued for 1 h 
under nitrogen at room temperature. Then the mixture was cooled to −30 °C, and NIS 
(232 mg, 1.03 mmol) and TMSOTf (13.3 μL, 0.074 mmol) were added, which made a 
black (maroon with most other alcohols) solution. After 2 h, satd aq Na2S2O3 was added 
to quench the reaction, and the dark color faded. The mixture was then filtered through 
Celite
®
, and the solution was concentrated in vacuo to give crude 3a. Other alcohols were 
reacted in a similar manner to give glycosides 3b–3m.  
(3). Acetylation of alkyl glycosides to give per-acetylated glycosides 4a–4c and 4e–
4m  
The residue from the foregoing step (3a) was dissolved in dry pyridine (10 mL), 
and 4-(dimethylamino)pyridine (DMAP, catalytic amt.) and Ac2O (1 mL, 10.6 mmol) 
were added with stirring overnight at room temperature. After concentrating the mixture, 




with satd aq NaHCO3 and brine, dried over anhyd Na2SO4, and concentrated in vacuo to 
afford the crude product 4a. In a similar manner compounds 4b–4c, 4e–4m were 
prepared. 
2.5.3 Experimental data for compounds 3d, 4, 4a–4c and 4e–4m 
 
Scheme 2.4 Synthesis of propargyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4a). 
The compound was synthesized according to the general glycosylation and 
acetylation procedures B.2 and B.3, above. The crude product was purified by silica gel 
chromatography (5:1 to 4:1, hexanes–EtOAc) to give 4a (106.7 mg, 75.1%, α/β = 10:1) 
as a mixture of isomers.  4aα: Rf 0.23 (2.5:1, hexanes–EtOAc). [α]D
20
 +148.5 (c 1.00, 
CHCl3). 
1
H NMR (500 MHz, CDCl3): δ 5.46 (1H, dd, J = 3.4, 1.4 Hz, H-4), 5.36 (1H, dd, 
J = 10.9, 3.4 Hz, H-3), 5.32 (1H, d, J = 3.6 Hz, H-1), 5.17 (1H, dd, J = 10.9, 3.7 Hz, H-





), 2.45 (1H, t, J = 2.4 Hz, CH2−C≡CH), 2.14, 2.08, 2.04, 1.98 (12H, 4s, 
4×COCH3). 
13
C NMR (125 MHz, CDCl3): δ: 170.50, 170.48, 170.29, 170.05 (4×COCH3) 
95.08 (C-1), 78.39 (CH2−C≡CH), 75.32 (CH2−C≡CH), 68.11 (C-4), 67.88 (C-2), 67.53 
(C-3), 66.94 (C-5), 61.63 (C-6), 55.43 (CH2−C≡CH), 20.91, 20.83, 20.78, 20.77 




 409.1111; found 
409.1114.  Compound 4a has been reported (NMR spectral data match those above) from 
the silica gel/H2SO4 glycosidation of the free sugar, a process I was unable to duplicate in 
yield and purity.
9







Scheme 2.5 Synthesis of propargyl 2,3,4,6-tetra-O-(acetyl-d3)-α-D-galactopyranoside (4). 
Compound 3a (64.3 mg, 0.295 mmol) was dissolved in dry pyridine (10 mL), and 
DMAP (catalytic amt.) and Ac2O-d6 (0.56 mL, 5.92 mmol) was added with stirring 
overnight at room temperature. After concentration, the residue was partitioned between 
CH2Cl2/water, and the organic layer was washed with satd aq NaHCO3 and brine, dried 
over anhyd Na2SO4 and concentrated in vacuo. The crude product was purified by silica 
gel chromatography (4:1 hexanes–EtOAc) to give 4 (106.1 mg, 90.4%) as a colorless 
syrup. Rf 0.23 (2.5:1, hexanes–EtOAc). [α]D
21
 +148.2 (c 1.00, CHCl3). 
1
H NMR (500 
MHz, CDCl3): δ 5.46 (1H, dd, J = 3.4, 1.4 Hz, H-4), 5.36 (1H, dd, J = 10.9, 3.3 Hz, H-3), 
5.31 (1H, d, J = 3.8 Hz, H-1), 5.16 (1H, dd, J = 10.9, 3.7 Hz, H-2), 4.26 (2H, dd, J = 2.4, 




), 2.45 (1H, t, J = 2.4 
Hz, CH2−C≡CH). 
13
C NMR (125 MHz, CDCl3): δ 170.49 (×2), 170.30, 170.05 
(4×COCH3) 95.06 (C-1), 78.38 (CH2−C≡CH), 75.31 (CH2−C≡CH), 68.06 (C-4), 67.83 





 421.2050; found 421.2048. 
 
Scheme 2.6 Synthesis of 3-(trimethylsilyl) propargyl 2,3,4,6-tetra-O-acetyl-α-D-




The compound was synthesized according to the general glycosylation and 
acetylation procedures B.2 and B.3, above. The crude product was purified by silica gel 
chromatography (5:1 to 4.5:1, hexanes–EtOAc) to give 4b (104.9 mg, 62.2%, α/β = 10:1) 
as a mixture of anomers.  4bα: Rf 0.37 (2.5:1, hexanes–EtOAc). [α]D
20
 144.4 (c 1.00, 
CHCl3). 
1
H NMR (500, CDCl3 MHz): δ 5.46 (1H, dd, J = 3.4, 1.3 Hz, H-4), 5.38 (1H, dd, 
J = 10.9, 3.4 Hz, H-3), 5.34 (1H, d, J = 3.7 Hz, H-1), 5.16 (1H, dd, J = 10.9, 3.7 Hz, H-




), 2.14, 2.09, 2.04, 1.99 
(12H, 4s, 4×COCH3), 0.17 (9H, s, −Si(CH3)3). 
13
C NMR (125 MHz, CDCl3): δ 170.51, 
170.36, 170.34, 170.11 (4×COCH3), 99.92 (CH2−C≡C−TMS), 94.71 (C-1), 92.52 
(CH2−C≡C−TMS), 68.11 (C-4), 67.93 (C-2), 67.56 (C-3), 66.84 (C-5), 61.58 (C-6), 
56.05 (CH2−C≡C−TMS), 20.93, 20.83, 20.81, 20.79 (4×COCH3), -0.16 (−Si(CH3)3). 




 481.1506; found 481.1507. 
 
Scheme 2.7 Synthesis of allyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4c). 
The compound was synthesized according to the general glycosylation and 
acetylation procedures B.2 and B.3, above. The crude product was purified by silica gel 
chromatography (5:1 to 4:1, hexanes–EtOAc) to give 4c (101. 2 mg, 70.9%, α/β = 7:1) as 
a mixture of anomers.  4cα: Rf 0.29 (2.5:1, hexanes–EtOAc). [α]D
20
 +163.0 (c 1.00, 
CHCl3). 
1
H NMR (500 MHz, CDCl3): δ 5.87 (1H, dddd, J = 17.2, 10.4, 6.1, 5.2 Hz, 
CH2CH=CH2) 5.45 (1H, dd, J = 3.4, 1.3 Hz, H-4), 5.38 (1H, dd, J = 12.0, 3.4 Hz, H-3), 
5.31 (1H, dq, J = 17.2, 1.6 Hz, CH2CH=CH2), 5.22 (1H, dq, J = 10.4, 1.3 Hz, 








), 4.09 (2H, m, CH2CH=CH2), 4.02 (1H, ddt, 13.1, 




), 2.13, 2.07, 2.04, 1.97 (12H, 4s, 4×COCH3). 
13
C NMR (125 MHz, 
CDCl3): δ 170.50, 170.48, 170.33, 170.09 (4×COCH3), 133.34 (CH2CH=CH2), 118.12 
(CH2CH=CH2), 95.47 (C-1), 68.90 (C-6), 68.25 (C-4), 68.21 (C-2), 67.73 (C-3), 66.49 





411.1267; found 411.1267.  The β anomer of compound 




Scheme 2.8 Synthesis of 2-nitroethyl α-D-galactopyranoside (3d). 
The compound was synthesized according to the general glycosylation procedures 
B.2 above (The compound partially decomposed when subjected to the acetylation 
conditions). The crude product was purified by silica gel chromatography (15:1 to 7:1, 
EtOAc–MeOH) to give 3d (86.6 mg, 93.0%, α/β = 5:1) as a mixture of anomers.  3dα: Rf 
0.43 (3:1, EtOAc–MeOH). [α]D
20
 +24.7 (c 1.00, CH3OH). 
1
H NMR (500 MHz, CD3OD): 
δ 4.94 (1H, d, J = 3.9 Hz, H-1), 4.78 (2H, m, OCH2CH2NO2), 4.33 (1H, ddd, J = 11.9, 
5.8, 4.6 Hz, OCH2CH2NO2), 4.04 (1H, ddd, J = 11.9, 5.8, 4.6 Hz, OCH2CH2NO2), 3.96 







C NMR (125 MHz, CD3OD): δ 100.91 (C-1), 75.87 (OCH2CH2NO2), 
72.60 (C-5), 71.24 (C-3), 71.05 (C-4), 69.90 (C-2), 65.06 (OCH2CH2NO2), 62.69 (C-6). 




276.0695; found 276.0694.  
Compound 3d has been reported.
47
 Partial characterization was by 
13
C NMR 





Scheme 2.9 Synthesis of 1,3-dichloro-2-propyl 2,3,4,6-tetra-O-acetyl-α-D-
galactopyranoside (4e).  
The compound was synthesized according to the general glycosylation and 
acetylation procedures B.2 and B.3, above. The crude product was purified by silica gel 
chromatography (5:1 to 4:1, hexanes–EtOAc) to give 4e (143.1 mg, 84.9%, α/β = 5:1) as 
a mixture of anomers.  4eα: Rf 0.38 (2:1, hexanes–EtOAc). [α]D
22
 +154.3 (c 1.00, 
CHCl3). 
1
H NMR (500 MHz, CDCl3): δ 5.48 (1H, dd, J = 3.4, 1.3 Hz, H-4), 5.36 (1H, d, 
J = 3.9 Hz, H-1), 5.34 (1H, dd, J = 11.0, 3.4 Hz, H-3), 5.08 (1H, dd, J = 11.0, 3.9 Hz, H-




), 4.00 (1H, m, 
CH(CH2Cl)2), 3.74 (2H, d, J = 5.1 Hz, CH(CH2Cl)2), 3.66 (2H, m, CH(CH2Cl)2), 2.14, 
2.08, 2.05, 2.00 (12H, 4s, 4×COCH3). 
13
C NMR (125 MHz, CDCl3): δ 170.77, 170.49, 
170.26, 170.07 (4×COCH3), 96.87 (C-1), 78.97 (CH(CH2Cl)2), 68.14 (C-2, C-4), 67.44 
(C-3), 67.34 (C-5), 62.14 (C-6), 44.16, 43.59 (CH(CH2Cl)2), 20.93, 20.80, 20.79, 20.75 




 481.0644; found 
481.0645, 483.0619, 485.0626 (ratio of molecular ion isotopic peak heights ≈ 9:6:1). 
 





The compound was synthesized according to the general glycosylation and 
acetylation procedures B.2 and B.3, above. The crude product was purified by silica gel 
chromatography (5:1 to 4.5:1, hexanes–EtOAc) to give 4f (96.5 mg, 56.0%, α/β = 3:1) as 
a mixture of anomers.  4fα: Rf 0.37 (2:1, hexanes–EtOAc). [α]D
20
 +98.6 (c 1.00, CHCl3). 
1
H NMR (500 MHz, CDCl3): δ 5.45 (1H, dd, J = 3.4, 1.4 Hz, H-4), 5.34–5.31 (1H, m, H-





), 3.87 (1H, ddd, J = 9.9, 6.0, 5.0 Hz, one of OCH2CH2CH2Br), 3.58–3.49 (3H, 
m, the other OCH2CH2CH2Br and two OCH2CH2CH2Br), 2.17–2.10 (5H, m, 
OCH2CH2CH2Br, COCH3), 2.08, 2.04, 1.98 (9H, 3s, 3 × COCH3). 
13
C NMR (125 MHz, 
CDCl3): δ 170.56, 170.49, 170.35, 170.20 (4 × COCH3), 96.63 (C-1), 68.26 (C-2), 68.19 
(C-4), 67.69 (C-3), 66.56 (C-5), 65.96 (OCH2CH2CH2Br), 61.91 (C-6), 32.15 
(OCH2CH2CH2Br), 30.17 (OCH2CH2CH2Br), 20.93, 20.86, 20.81, 20.78 (4×COCH3). 




491.0529, 493.0511; found 
491.0526, 493.0502 (ratio of molecular ion isotopic peak heights ≈ 1:1).  Compound 4f 
has been reported.
48
 NMR spectral data match those above. 
 
Scheme 2.11 Synthesis of 5-hexynyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4g). 
The compound was synthesized according to the general glycosylation and 
acetylation procedures B.2 and B.3, above. The crude product was purified by silica gel 
chromatography (5:1 to 4.5:1, hexanes–EtOAc) to give 4g (66.3 mg, 42.1%, α/β > 20:1) 
as a colorless syrup.  4gα: Rf 0.38 (2:1, hexanes–EtOAc). [α]D
20
 +139.1 (c 1.00, CHCl3). 
1









), 3.73 (1H, dt, J = 9.9, 6.1 Hz, one of OCH2CH2CH2CH2−C≡CH 3.45 (1H, dt, J 
= 9.9, 6.3 Hz, the other one of OCH2CH2CH2CH2−C≡CH), 2.23 (2H, tdd, J = 6.9, 2.7, 
0.7 Hz, OCH2CH2CH2CH2− C≡CH), 2.14, 2.07, 2.04, 1.98 (12H, 4s, 4×COCH3), 1.95 
(1H, t, J = 2.6 Hz, OCH2CH2CH2CH2−C≡CH), 1.75 – 1.69 (2H, m, 
OCH2CH2CH2CH2−C≡CH), 1.64–1.59 (2H, m, OCH2CH2CH2CH2−C≡CH). 
13
C NMR 
(125 MHz, CDCl3): δ 170.56, 170.54, 170.37, 170.17 (4×COCH3), 96.29 (C-1), 84.10 
(OCH2CH2CH2CH2−C≡CH), 68.85 (OCH2CH2CH2CH2−C≡CH), 68.36 (C-2), 68.26 (C-
4), 68.16 (OCH2CH2CH2CH2−C≡CH), 67.80 (C-3), 66.39 (C-5), 61.96 (C-6), 28.45 
(OCH2CH2CH2CH2−C≡CH), 25.21 (OCH2CH2CH2CH2−C≡CH), 20.93, 20.84, 20.81, 





 451.1580; found 451.1580.  
 
Scheme 2.12 Synthesis of benzyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4h). 
The compound was synthesized according to the general glycosylation and 
acetylation procedures B.2 and B.3, above. The crude product was purified by silica gel 
chromatography (5:1 to 4.5:1, hexanes–EtOAc) to give 4h (116.5 mg, 72.3%, α/β = 3:1) 
as a mixture of anomers.  4hα: Rf 0.40 (2:1, hexanes–EtOAc). [α]D
21
 +126.8 (c 1.00, 
CHCl3). 
1
H NMR (500 MHz, CDCl3): δ 7.37–7.31 (5H, m, Harom), 5.46 (1H, dd, J = 3.5, 
1.3 Hz, H-4), 5.40 (1H, dd, J = 10.7, 3.4 Hz, H-3), 5.18 (1H, d, J = 3.7 Hz, H-1), 5.14 








), 2.13, 2.05, 2.03, 
1.98 (12H, 4s, 4×COCH3). 
13
C NMR (125 MHz, CDCl3): δ 170.50, 170.40, 170.33, 
170.11 (4×COCH3), 136.90, 128.65, 128.24, 128.01 (Carom), 95.52 (C-1), 70.09 (CH2Ph), 
68.23 (C-4), 68.20 (C-2), 67.78 (C-3), 66.63 (C-5), 61.81 (C-6), 20.86, 20.84, 20.79, 





461.1426.  Compound 4h has been used in experiments apparently without 
characterization.
49




Scheme 2.13 Synthesis of propargyl 2,3,4,6-tetra-O-acetyl-α-D-glucopyranoside (4i). 
The compound was synthesized according to the general glycosylation and 
acetylation procedures B.2 and B.3, above. The crude product was purified by silica gel 
chromatography (5:1 to 4:1, hexanes–EtOAc) to give 4i (112.8 mg, 79.4%, α/β = 7:1) as 
a mixture of anomers.  4iα: Rf 0.35 (2:1, hexanes–EtOAc). [α]D
21
 +163.6 (c 1.00, CHCl3). 
1
H NMR (500 MHz, CDCl3): δ 5.48 (1H, m, H-3), 5.28 (1H, d, J = 3.8 Hz, H-1), 5.08 
(1H, dd, J = 10.1, 9.4 Hz, H-4), 4.91 (1H, dd, J = 10.3, 3.8 Hz, H-2), 4.27 (2H, d, J = 2.4 




), 4.04 (1H, m, H-5), 2.44 (1H, t, J = 2.4 
Hz, CH2−C≡CH), 2.08, 2.07, 2.02, 2.00 (12H, 4s, 4×COCH3). 
13
C NMR (125 MHz, 
CDCl3): δ 170.75, 170.22, 170.14, 169.66 (4×COCH3) 94.69 (C-1), 78.28 (CH2−C≡CH), 
75.41 (CH2−C≡CH), 70.56 (C-2), 70.04 (C-3), 68.52 (C-4), 67.94 (C-5), 61.82 (C-6), 





 409.1111; found 409.1112.  Compound 4i has been reported.
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Scheme 2.14 Synthesis of propargyl 2,3,4,6-tetra-O-acetyl-β-D-mannopyranoside (4j). 
The compound was synthesized according to the general glycosylation and 
acetylation procedures B.2 and B.3, above. The crude product was purified by silica gel 
chromatography (4:1 to 2.5:1, hexanes–EtOAc) to give 4j (115.6 mg, 81.4%, α/β = 1:2) 
as a mixture of anomers.  4jβ: Rf 0.18 (2:1, hexanes–EtOAc). [α]D
20
 −82.8 (c 1.00, 
CHCl3). 
1
H NMR (500 MHz, CDCl3): δ 5.48 (1H, dd, J = 3.3, 1.1 Hz, H-2), 5.26 (1H, t, J 
= 9.9 Hz, H-4), 5.09 (1H, dd, J = 10.0, 3.3 Hz, H-3), 4.94 (1H, d, J = 1.1 Hz, H-1), 4.38 
(2H, m, CH2−C≡CH), 4.31 (1H, dd, J = 12.3, 5.3 Hz, H-6
a
), 4.16 (1H, dd, J = 12.3, 2.5 
Hz, H-6
b
), 3.69 (1H, ddd, J = 9.9, 5.3, 2.6 Hz, H-5), 2.48 (1H, t, J = 2.4 Hz, 
CH2−C≡CH), 2.17, 2.08, 2.03, 1.98 (12H, 4s, 4×COCH3). 
13
C NMR (125 MHz, CDCl3): 
δ 170.79, 170.36, 170.10, 169.68 (4×COCH3), 95.76 (C-1, JC1-H1 = 158.76 Hz), 77.94 
(CH2−C≡CH), 76.09 (CH2−C≡CH), 72.66 (C-5), 71.21 (C-3), 68.85 (C-2), 66.08 (C-4), 
62.45 (C-6), 55.91 (CH2−C≡CH), 20.95, 20.88, 20.81, 20.69 (4×COCH3). HRESIMS: 




 409.1111; found 409.1111. The JC1−H1 cited 
above is in line with that generally expected for a β-D-mannopyranoside.
51
 A recent 







Scheme 2.15 Synthesis of propargyl 6-O-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl)-
2,3,4-tri-O-acetyl-α-D-glucopyranoside (4k).  
The compound was synthesized according to the general glycosylation and 
acetylation procedures B.2 and B.3, above. The crude product was purified by silica gel 
chromatography (2:1, hexanes–EtOAc) to give 4k (172.1 mg, 69.4%, α/β = 8:1) as a 
mixture of anomers.  4kα: Rf 0.29 (1:1, hexanes–EtOAc). [α]D
20
 +166.2 (c 1.00, CHCl3). 
1
H NMR (500 MHz, CDCl3): δ 5.48 (1H, dd, J = 10.3, 9.3 Hz, H-3), 5.45 (1H, dd, J = 
3.4, 1.3 Hz, H-4’), 5.34 (1H, dd, J = 10.8, 3.3 Hz, H-3’), 5.24 (1H, d, J = 3.7 Hz, H-1), 
5.16 (1H, d, J = 3.7 Hz, H-1’), 5.11 (1H, dd, J = 10.8, 3.6 Hz, H-2’), 5.05 (1H, dd, J = 
10.2, 9.3 Hz, H-4), 4.85 (1H, dd, J = 10.3, 3.8 Hz, H-2), 4.28 (2H, dd, J = 2.5, 0.7 Hz, 
CH2−C≡CH), 4.25 (1H, m, H-5’), 4.07 (2H, m, H-6’
a,b
), 4.02 (1H, m, H-5), 3.72 (1H, dd, 
J = 11.3, 5.4 Hz, H-6
a
), 3.55 (1H, dd, J = 11.3, 2.4 Hz, H-6
b
), 2.49 (1H, t, J = 2.4 Hz, 
CH2−C≡CH), 2.13, 2.11, 2.07, 2.04, 2.03, 2.00, 1.97 (21H, 7s, 7×COCH3). 
13
C NMR 
(125 MHz, CDCl3): δ 170.66, 170.52, 170.32, 170.27, 170.19, 170.00, 169.64 
(7×COCH3), 96.39 (C-1’), 94.49 (C-1), 78.31 (CH2−C≡CH), 75.57 (CH2−C≡CH), 70.63 
(C-2), 70.09 (C-3), 69.16 (C-4), 68.93 (C-5), 68.27 (C-4’), 68.25 (C-2’), 67.60 (C-3’), 
66.58 (C-5’), 66.31 (C-6), 61.90 (C-6’), 55.51 (CH2−C≡CH), 20.94, 20.86, 20.82, 20.81 









Scheme 2.16 Synthesis of propargyl 4-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-
2,3,6-tri-O-acetyl-α-D-glucopyranoside (4l).  
The compound was synthesized according to the general glycosylation and 
acetylation procedures B.2 and B.3, above. The crude product was purified by silica gel 
chromatography (2:1 to 1.5:1, hexanes–EtOAc) to give 4l (140.6 mg, 56.7%, α/β = 12:1) 
as a mixture of anomers.  4lα: Rf 0.22 (1:1, hexanes–EtOAc). [α]D
22
 +59.7 (c 1.00, 
CHCl3). 
1
H NMR (500 MHz, CDCl3): δ 5.47 (1H, dd, J = 10.3, 9.2 Hz, H-3), 5.34 (1H, 
dd, J = 3.6, 1.2 Hz, H-4’), 5.20 (1H, d, J = 3.8 Hz, H-1), 5.10 (1H, dd, J = 10.4, 7.9 Hz, 
H-2’), 4.95 (1H, dd, J = 10.4, 3.5 Hz, H-3’), 4.83 (1H, dd, J = 10.3, 3.8 Hz, H-2), 4.48 
(1H, d, J = 7.9 Hz, H-1’), 4.45 (1H, dd, J = 12.0, 2.1 Hz, H-6
a
), 4.25 (2H, dd, J = 3.3, 2.4 




), 4.07 (1H, dd, J = 11.1, 7.5 Hz, H-6’
b
), 3.96 
(1H, m, H-5), 3.86 (1H, ddd, J = 7.5, 6.3, 1.2 Hz, H-5’), 3.76 (1H, dd, J = 10.1, 9.2 Hz, 
H-4), 2.43 (1H, t, J = 2.4 Hz, CH2−C≡CH), 2.14, 2.12, 2.06, 2.05, 2.04, 2.04, 1.95 (21H, 
7s, 7×COCH3). 
13
C NMR (125 MHz, CDCl3): δ 170.50, 170.48, 170.47, 170.30, 170.21, 
169.59, 169.13 (7×COCH3), 101.16 (C-1’), 94.41 (C-1), 78.30 (CH2−C≡CH), 76.42 (C-
4), 75.37 (CH2−C≡CH), 71.19 (C-3’), 70.79 (C-2), 70.77 (C-5’), 69.76 (C-3), 69.27 (C-
2’), 68.85 (C-5), 66.74 (C-4’), 61.86 (C-6), 60.94 (C-6’), 55.30 (CH2−C≡CH), 21.00 








697.1956; found 697.1956. Compound 4l has been reported.
12
 
However, the NMR data differ from those I report and assign above. Our assignments are 
based on 2D NMR data.  See the NMR spectra in the Supplementary Information section.  
 
Scheme 2.17 Synthesis of propargyl 3,4,6-tri-O-acetyl-2-deoxy-α,β-D-lyxo-
hexopyranoside (4m).   
In addition, the thiophenyl glycoside (donor) of 2-deoxy-D-lyxo-hexopyranose 
(phenyl 2-deoxy-1-thio-β-D-lyxo-hexopyranoside, 1f) was also synthesized and applied in 
this glycosylation reaction to afford propargyl 3,4,6-tri-O-acetyl-2-deoxy-α,β-D-lyxo-
hexopyranoside (alias: “propargyl 3,4,6-tri-O-acetyl-2-deoxy-α,β-D-galactopyranoside,” 
4m).
53
 However, a moderate yield (67%) and low stereoselectivity (α:β = 1.7:1) were 
achieved. The acetylated mixture 4m was not further separated into its anomers. 
2.6 Conclusions 
In summary, a facile and general strategy for the direct construction of 1,2-cis 
alkyl glycosides has been developed. Glycosylations between several unprotected phenyl 
1-thioglycosyl donors and alcohols bearing various functional groups proceed smoothly 
to give satisfying yields and 1,2-cis selectivity. Use of an FIA–ESI-TOF-MS/NMR 
protocol facilitated rapid and efficient optimization of conditions. I anticipate that the 
synthetic procedures described herein will find application in a number of areas where 
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In order to construct a synthetic carbohydrate microarray to imitate featured 
carbohydrate presentations on cell surface, I have developed straightforward synthetic 
routes for the preparation of α-linked propargyl terminated galactosides with various 
spatial presentations. Through the routes, glycosyl acceptors were obtained via flexible 
and efficient regioselective protection strategies, which were followed by glycosylations 
with 4,6-di-tert-butylsilylene protected thiogalactoside donor to get the α-linked 
galactosides in exclusive stereoselective and satisfied yield. These galactoside ligands 



















Cell membranes are extensively covered with oligosaccharides and 
glycoconjugates, which have been determined to be crucial in mediating many biological 
processes, such as cell adhesion, cell recognition, ion conductivity and cell signaling.
1
 
The carbohydrate landscape provides an ideal basis for these biological functions, which 
are based on their highly branched structures and varied linkage types. Moreover, 
carbohydrates can modify the intrinsic properties of proteins to which they are attached 
by altering the stability, protease resistance, quaternary structure, and dynamics 
involved.
2
 However, explaining the mechanisms involved is still challenging. 





 enables us to explore the mechanisms systematically.  
Our goal is to emulate this cell membrane landscape by construction of 
microarrays with a collection of diversely presented carbohydrate ligands. Glycoclusters 
with capped-galactose will be assembled in a modular fashion and immobilized on glass 
surfaces at defined densities to control molecular presentation. The compounds 
synthesized will be new glycoclusters of α-galactose units that mimic features of 
carbohydrates on cell surfaces. The significance of α-galactosides has been well 
documented, as they are extensively involved in many biological recognition processes, 
such as being ABO histo-blood antigens,
7, 8
 Chagas disease antigens,
9
 and precursors of 
Fabry disease symptoms pathogenesis.
10
 Recently, Commins and co-workers reported the 
anaphylaxis to mammalian red meat that is caused by the serum anti-α-Gal IgE antibodies 
to the oligosaccharides with the Gal-α-(1,3)-Gal structure.
11
 They demonstrated that IgE 




americanum). These patients are then experienced severe hypersensitivity reactions after 




As the type of linkage from a sugar cap on an oligosaccharide to the neighboring 
sugar residue is a major distinguishing feature among natural galactans, I want to 
systematically investigate the influence of linkage type and size of α-linked galactosides 
on their binding with receptors, and get more insights in elucidating the recognition 
mechanism and developing novel diagnostic methods and therapies. This chapter will 
primarily focus on the synthesis of α-linked galactoside ligands. Six propargyl-terminated 
galactose derivatives will be synthesized with totally 1,2-cis-α-O-glycosidic linkages. I 
synthesized a collection of galactoside ligands (α-linked 1,2-, 1,3-, 1,4- and 1,6- galactose 
disaccharides, as well as mono- and α-linked trisaccharide, as displayed in Figure 3.1, 
compounds 1–6). The installed propargyl terminus of galactosides enables rapid and 
efficient incorporation with an azide-terminated cluster via “click chemistry”,
13
 which 
allows a quantitative introduction of glycosyl groups onto carbohydrate microarray 
surface. Furthermore, a previous study conducted in our lab revealed that the α-linked 
mannose disaccharide presented highest binding affinity with Con A lectin compared 
with mono- and trisaccharide.
14
 Therefore, I intentionally designed the following 
galactoside candidates. 
Herein, I will take advantage of combinatorial synthesis for the construction of 
the propargyl galactoside ligands. Combinatorial synthesis is an efficient means of 
making several compounds simultaneously from different combinations of modular 
building blocks.
15, 16










Figure 3.1 Structures of defined α-linked galactosides with propargyl terminus to be 





































































oligosaccharides, which can be efficiently achieved through the combinations of different 
glycosyl donors and acceptors. In most cases, the benzyl ether protecting group is a 
popular choice in 1,2-cis-glycosylation reactions based on the virtue of non-participation 
during glycosylations, but debenzylation always needs H2/Pd system that would destroy 
the propargyl terminus. Therefore, the selection of a protecting group that favors 1,2-cis-
glycosylation and tolerates propargyl group as well is a main challenge. 
In 2003, Kiso et al. first reported
17
 the employment of di-tert-butylsilylene 
(DTBS) protecting group in presence of C-2 benzoyl participating groups in α-selective 
galactosylation. The cyclic bifunctional silyl protecting groups present strong power in 
controlling the α-stereoselectivity of glycosylation. Accordingly, the 2,3-di-O-benzoyl-
4,6-O-di-tert-butylsilanediyl protected galactosyl donors have been prepared and used in 
many α-galactosylations.
18
 The highly bulky silyl group blocks the β-face of the donor to 
guarantee a completely α-glycosylation with the glycosyl acceptor.
19
 This type of donor 
shows great accessibility, compatibility, and most importantly, high tolerance with 
sensitive groups such as alkene, alkyne, nitro and halogen. The deprotection of silyl and 
benzoyl group can be performed at mild conditions without impairing the anomeric 
functional groups, which satisfies our requirements in the synthesis of α-linked propargyl 
galactoside ligands. 
Combinatorial synthesis was performed to afford the α-linked galactose ligands 
1–6 from different combinations of glycosyl donor and acceptors. Propargyl α-D-
galactoside 1 was synthesized according to the method described in Chapter 2, through 
the glycosylation of unprotected 1-thiogalactosyl donor with propargyl alcohol.
20
 It was 
then regioselectively protected by different strategies
21–23




four galactose acceptors 7–9 and 11 with propargyl terminus, which are 2, 3, 4, 6 –OH 
free respectively. For the synthesis of the acceptors 7 and 8, I developed a concise 
method. The galactoside 1 was protected with the bifunctional silyl-protecting group to 
have the compound with the 4 and 6 –OH blocked, and it was treated with an equimolar 
benzoyl chloride. As the reactivities of 2 and 3 –OH of galactose are similar, it gave both 
acceptors 7 and 8 at the same time. To the best of our knowledge, these synthetic 
approaches used minimal steps and protecting group manipulations (Scheme 3.1). 
 
Scheme 3.1 Synthesis of the glycosylation acceptors 7–9 and 11. Reagents and 
conditions: (a) DTBS(OTf)2, DMF, –40 °C, 83%; (b) BzCl, Pyridine, 47% for 7, 30% for 
8; (c) BzCl, Pyridine,  –30 °C, 48%; (d) TBDMSCl, Imidazole, Pyridine, 65%; (e) BzCl, 
Pyridine, DMAP, 63%; (f) TBAF, AcOH, THF, 84%. 
The synthesized glycosyl acceptors were glycosylated with the α-directing 
glycosyl donor 12
17
 upon the activation with trifluoromethanesulfonic acid (TfOH) and 
N-iodosuccinimide (NIS). Expected α-configurations were achieved in moderate to high 
yield (Scheme 3.2). It is noteworthy that acceptors 7–9 and 11, yet having similar 




Accordingly, besides the conventional glycosylation procedure (with acceptor 11), an 
inverse-addition (I-A) procedure
24
 (with acceptors 7–9) was also applied to achieve more 
effective glycosylation and to optimize the yield. I speculate that the I-A procedure favors 
the formation of oxocarbenium ion due to kinetic anomeric effect and through-space 
electron donation effect,
19
 which enables weakly nucleophilic acceptors (such as these 
secondary alcohols) to attack it through SN1 process. Removal of the silyl and benzoyl 
groups furnished the α-linked disaccharides 2-5 (Scheme 3.3). 
 
 
Scheme 3.2 Synthesis of disaccharides 13–16. Reagents and conditions: (g) NIS, TfOH, 





Scheme 3.3 Deprotection of disaccharides 13–16 to afford 2–5. Reagents and conditions: 
(i) TBAF, AcOH; (j) NaOMe, MeOH, 72–84% over two steps. 
 
Scheme 3.4 Synthesis of trisaccharide 6. Reagents and conditions: (d) TBDMSCl, 
Imidazole, Pyridine; (e) BzCl, Pyridine, DMAP; (f) TBAF, AcOH, THF; (h) NIS, TfOH, 
CH2Cl2, 0 °C; (i) TBAF, AcOH; (j) NaOMe, MeOH; (k) Ac2O, DMAP, Pyridine, 11% 
over 8 steps. 
The synthesis of trisaccharide 6 was in a similar fashion with disaccharide 5, as 
they shared the same Gal-α-(1,6)-Gal structure. Regioselective protection of disaccharide 




the α-1-6-linkage at the top. Deprotection of 18 afforded the trisaccharide 6, which was 
acetylated again for a further purification and better characterization. Final deprotection 
by sodium methoxide gave defined trisaccharide 6 in high purity (Scheme 3.4). 
3.2 Experimental Section 
3.2.1 General methods 
All chemicals were purchased as reagent grade and used without further 
purification, unless otherwise noted. Reagent grade dichloromethane (CH2Cl2), diethyl 
ether (Et2O), tetrahydrofuran (THF), methanol (MeOH), N,N-dimethylformamide (DMF) 
and toluene were obtained from the Pure-Solv (Innovation Technologies) solvent system 
that uses alumina columns except for DMF, which was dried over a column of 5 Ǻ 
molecular sieves. Pyridine was distilled over CaH2 prior to use. All reactions were 
performed under anhydrous conditions unless otherwise noted. Reactions were monitored 
by thin-layer chomatography (TLC) on silica gel precoated aluminum plates. Zones were 
detected by UV irradiation using a 254 nm lamp and/or by heat/charring with p-
anisaldehyde–sulfuric acid development reagent. Column chomatography was performed 
on silica gel (40−63 μm). Optical rotation values were obtained at the sodium D line 
using a Perkin–Elmer 241 polarimeter. 
1
H (500 MHz) and 
13
C NMR (125 MHz) spectra 
were recorded at room temperature with a Varian Inova 500 MHz instrument. Chemical 
shifts are reported in δ-units (ppm) relative to the residual 
1
H CDCl3 at δ 7.26 ppm and 
13
C at δ 77.16 ppm. All two-dimensional experiments (gCOSY, gHSQC and gHMBC) 
were recorded on the same instrument using Varian protocols. Mass spectrometric 




spectrometer with an ESI source. MALDI-TOF mass spectra were obtained on a 
Voyager-DE PRO BioSpectrometry workstation. 
3.2.2. Synthesis of carbohydrate ligands  
(1) Synthesis of the phenyl thioglycoside donor.  
 
Scheme 3.5 Synthesis of phenyl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-galactopyranoside 21. 
Thiophenol (2.78 mL, 27.2 mmol) was added to a solution of compound 20 (8.15 
g, 20.9 mmol) in dry CH2Cl2 at 0 °C and the mixture was stirred for 30 min. Then 
BF3·Et2O (7.95 mL, 62.7 mmol) was slowly injected to the mixture, which was allowed 
to warm to room temperature. After 5 hours, the mixture was diluted by CH2Cl2, washed 
with sat NaHCO3 and brine, dried over Na2SO4, concentrated in vacuo, and purified by 
column chromatography (Hexane–EtOAc 6:1) to afford compound 21 as colorless syrup 
(7.56 g, 82.2%). Rf = 0.39 (2.5:1, hexane–EtOAc). [α]D
23
 = + 3.6 (c = 1.00, CHCl3). 
1
H 
NMR (500 MHz, Chloroform-d) δ 7.50 (m, 2H, Ar-H), 7.30 (m, 3H, Ar-H), 5.41 (dd, J = 
3.4, 1.1 Hz, 1H, H-4), 5.23 (m, 1H, H-2), 5.06 (dd, J = 10.0, 3.4 Hz, 1H, H-3), 4.73 (d, J 
= 10.0 Hz, 1H, H-1), 4.18 (m, 1H, H-6a), 4.11 (m, 1H, H-6b), 3.94 (ddd, J = 7.1, 6.2, 1.1 
Hz, 1H, H-5), 2.10, 2.08, 2.03, 1.96 (4s, 12H, 4×COCH3). 
13
C NMR (126 MHz, 
Chloroform-d) δ 170.35, 170.18, 170.02, 169.42, 132.58, 132.49, 128.91, 128.17, 86.56, 





Scheme 3.6 Synthesis of phenyl 1-thio-β-D-galactopyranoside 22.
 
 
Compound 21 (5.85 g, 13.3 mmol) was dissolved in dry MeOH (50 mL), 
followed by adding NaOMe in small amount to afford pH 9. After 2 h the solution was 
quenched by Amberlite
®
 IR 120 (H
+
). The resin was filtered off and the solvent was 
removed in vacuo to afford a white powdery solid 22 (3.53 g, 97.6%). Rf = 0.53 (4:1, 
EtOAc–MeOH). m.p. 106 – 108 °C. [α]D
21
 = - 48.4 (c = 0.93, CH3OH). 
1
H NMR (500 
MHz, Methanol-d) δ 7.58 (m, 2H, Ar-H), 7.31 (m, 2H, Ar-H), 7.25 (m, 1H, Ar-H), 4.63 
(d, J = 9.7 Hz, 1H, H-1), 3.93 (dd, J = 3.4, 1.0 Hz, 1H), 3.80 (m, 1H), 3.74 (m, 1H), 3.64  
(t, J = 9.4 Hz, 1H), 3.59 (ddd, J = 6.6, 5.3, 1.1 Hz, 1H), 3.54 (dd, J = 9.2, 3.3 Hz, 1H). 
13
C NMR (126 MHz, Methanol-d) δ 136.00, 132.05, 129.82, 127.97, 90.22, 80.55, 76.29, 
70.98, 70.38, 62.59. 
 
Scheme 3.7 Synthesis of phenyl 4,6-O-di-tert-butylsilanediyl-1-thio-β-D-
galactopyranoside 23. 
Compound 22 (3.53 g, 13.0 mmol) was dissolved in dry DMF (40 mL) and cooled 
to -40 °C. Di-tert-butylsilyl bis(trifluoromethanesulfonate) (4.02 mL, 12.3 mmol) was 




pyridine (3.2 mL). The reaction mixture was stirred for another 15 min, then diluted with 
diethyl ether, washed by water (200 mL) and brine (100 mL) and dried over anhydrous 
Na2SO4. The organic layer was concentrated in vacuo and purified by column 
chromatography (DCM/Acetone 15:1 to 10:1) to afford compound 23 (4.83 g, 90.2%) as 
colorless syrup. Rf = 0.56 (10:1, DCM–Acetone). [α]D
22
 = -78.0 (c = 1.00, CHCl3). 
1
H 
NMR (500 MHz, Chloroform-d) δ 7.57 (m, 2H, Ar-H), 7.30 (m, 3H, Ar-H), 4.57 (d, J = 
9.8, 1H, H-1), 4.45 (dd, J = 3.5, 1.1 Hz 1H), 4.27 (m, 2H), 3.76 (td, J = 9.4, 2.5 Hz, 1H), 
3.55 (ddd, J = 10.5, 8.9, 3.5 Hz, 1H), 3.48 (m, 1H), 2.81 – 2.70 (br, 2s, 2H, OH), 1.06 (s, 
9H), 1.05 (s, 9H). 
13
C NMR (126 MHz, Chloroform-d) δ 133.27, 132.77, 129.07, 128.02 
(Ar-C), 89.21 (C-1), 75.37, 75.27, 72.67, 70.83, 67.22, 27.69, 27.55, 23.47, 20.79.  
 
Scheme 3.8 Synthesis of phenyl 2,3-di-O-benzoyl-4,6-O-di-tert-butylsilanediyl-1-thio-β-
D-galactopyranoside 12.  
Compound 23 (4.28 g, 10.39 mmol) was dissolved in dry pyridine (30 mL), 
followed by adding benzoyl chloride (2.90 mL, 24.96 mmol) at room temperature. The 
reaction mixture was stirring for 3 hours, which was then quenched by EtOH (5 mL) and 
concentrated in high vacuo. The residue was diluted by EtOAc (60 mL), washed with 1N 
HCl (50 mL), sat. aq. NaHCO3 (60 mL) and brine (50 mL). The aqueous layer was 
extracted with EtOAc (60 mL), and the combined organics were dried over anhydrous 




chromatography (10:1, hexane–EtOAc) to give 12 (5.69 g, 88.3%) as a white solid. Rf = 
0.32 (6:1, hexane–EtOAc). m.p. 72 – 74 °C. [α]D
22
 = +136.9 (c = 1.03, CHCl3). 
1
H NMR 
(500 MHz, Chloroform-d) δ 7.99 (ddd, J = 8.5, 5.0, 1.3 Hz, 4H, Ar-H), 7.49 (m, 4H, Ar-
H), 7.38 (m, 4H, Ar-H), 7.26 (m, 3H, Ar-H), 5.93 (t, J = 10.0 Hz, 1H, H-2), 5.22 (dd, J = 
9.8, 3.1 Hz, 1H, H-3), 4.95 (d, J = 10.1 Hz, 1H, H-1), 4.89 (dd, J = 3.1, 0.9 Hz, 1H, H-4), 
4.33 (m, 2H, H-6a,b), 3.65 (q, J = 1.3 Hz, 1H, H-5), 1.16 (s, 9H, CH3-tBu-Si), 0.96 (s, 9H, 
CH3-tBu-Si). 
13
C NMR (126 MHz, Chloroform-d) δ 166.27, 165.58, 133.94, 133.37, 
133.29, 132.60, 129.95, 129.93, 129.75, 129.59, 129.04, 128.53, 128.49, 127.94, 87.67, 
75.61, 75.16, 70.61, 68.26, 67.27, 27.65, 27.60, 23.40, 20.86. MALDI-TOFMS: calcd for 
C34H40O7SSi·Na
+
: 643.2156; found: m/z 643.2146. 
(2) Synthesis of galactosyl acceptors 
 
Scheme 3.9 Synthesis of propargyl 4,6-O-di-tert-butylsilanediyl-α-D-galactopyranoside 
24.  
Compound 1 (1.91 g, 8.76 mmol) was dissolved in dry DMF (20 mL) and cooled 
to -40 °C. Di-tert-butylsilyl bis(trifluoromethanesulfonate) (2.70 mL, 8.32 mmol) was 
added dropwise to the mixture, which was stirred for 30 min, followed by addition of 
pyridine (2.1 mL). The reaction mixture was stirred for another 15 min, then diluted with 
diethyl ether, washed by water (100 mL) and brine (100 mL) and dried over anhydrous 




chromatography (DCM/Acetone 40:1 to 20:1) to afford compound 24 (2.59 g, 82.6%) as 
an amorphous white foam. Rf = 0.41 (9:1, DCM–Acetone). [α]D
22
 = 138.6 (c = 1.00, 
CHCl3). 
1
H NMR (500 MHz, Chloroform-d) δ 5.13 (d, J = 3.9, 1H, H-1), 4.46 (dd, J = 
3.5, 1.2 Hz, 1H), 4.30 – 4.27 (m, 3H), 4.18 (dd, J = 12.6, 1.7 Hz, 1H), 3.88 (dd, J = 9.8, 
3.9 Hz, 1H), 3.80 (m, 1H), 3.72 (dd, J = 9.8, 3.4 Hz, 1H), 2.45 (t, J = 2.4 Hz, 1H), 1.05 
(s, 9H), 1.03 (s, 9H). 
13
C NMR (126 MHz, Chloroform-d) δ 98.18, 78.93, 75.12, 73.32, 





 381.1709, found 381.1709. 
 
Scheme 3.10 Synthesis of propargyl 3-O-benzoyl-4,6-O-di-tert-butylsilanediyl-α-D-
galactopyranoside 7 and propargyl 2-O-benzoyl-4,6-O-di-tert-butylsilanediyl-α-D-
galactopyranoside 8.  
Compound 24 (1.69 g, 4.72 mmol) was dissolved in dry pyridine (20 mL), 
followed by adding benzoyl chloride (0.58 mL, 4.96 mmol) at room temperature. The 
reaction mixture was stirring for 1 hour, which was then quenched by EtOH (2 mL) and 
concentrated in high vacuo. The residue was diluted by EtOAc (60 mL), washed with 1N 
HCl (50 mL), sat. aq. NaHCO3 (60 mL) and brine (50 mL). The aqueous layer was 
extracted with EtOAc (60 mL), and the combined organics were dried over anhydrous 
Na2SO4. After concentration, the crude products were purified by silica gel 




as amorphous white foam. 8: Rf = 0.47 (3:1, hexane–EtOAc). [α]D
20
 = +97.2 (c = 1.00, 
CHCl3). 
1
H NMR (500 MHz, Chloroform-d) δ 8.12 (m, 2H, Ar-H), 7.56 (m, 1H, Ar-H), 
7.44 (m, 2H, Ar-H), 5.39 (dd, J = 10.2, 3.7 Hz, 1H), 5.30 (d, J = 3.8 Hz, 1H, H-1), 4.54 
(dd, J = 3.5, 1.3 Hz, 1H), 4.33 (dd, J = 12.7, 2.2 Hz, 1H), 4.26 (dd, J = 3.1, 2.4 Hz, 2H), 
4.22 (dd, J = 12.6, 1.6 Hz, 1H), 4.11 (m, 1H), 3.90 (m, 1H), 2.58 (m, 1H), 2.33 (t, J = 2.4 
Hz, 1H), 1.11 (s, 9H, CH3-tBu-Si), 1.07 (s, 9H, CH3-tBu-Si). 
13
C NMR (126 MHz, 
Chloroform-d) δ 166.86, 133.27, 130.06, 129.99, 128.46, 96.45, 79.02, 74.82, 73.78, 
71.34, 68.52, 67.81, 66.80, 55.64, 27.68, 27.41, 23.52, 20.90. MALDI-TOFMS: calcd for 
C24H34O7Si·Na
+
: 485.1972; found: m/z 485.1972. 7: Rf = 0.42 (3:1, hexane–EtOAc). 
[α]D
20
 = +182.6 (c = 1.00, CHCl3). 
1
H NMR (500 MHz, Chloroform-d) δ 8.11 (m, 2H, 
Ar-H), 7.57 (m, 1H, Ar-H), 7.45 (m, 2H, Ar-H), 5.23 (dd, J = 10.4, 3.2 Hz, 1H), 5.19 (d, 
J = 3.9 Hz, 1H, H-1), 4.72 (m, 1H), 4.34 (m, 3H), 4.30 (dd, J = 12.6, 2.2 Hz, 1H), 4.21 
(dd, J = 12.6, 1.7 Hz, 1H), 3.87 (m, 1H), 2.47 (t, J = 2.4 Hz, 1H), 2.04 (m, 1H), 1.07 (s, 
9H, CH3-tBu-Si), 0.98 (s, 9H, CH3-tBu-Si). 
13
C NMR (126 MHz, Chloroform-d) δ 166.91, 
133.25, 130.29, 129.95, 128.50, 98.37, 78.85, 75.24, 73.83, 71.49, 68.00, 66.97, 66.85, 
55.50, 27.69, 27.35, 23.43, 20.84. MALDI-TOFMS: calcd for C24H34O7Si·Na
+
: 
485.1972; found: m/z 485.1972. 
 
Scheme 3.11 Synthesis of propargyl 2,3,6-tri-O-benzoyl-α-D-galactopyranoside 9. 
Benzoyl chloride (1.15 mL, 9.89 mmol) was added dropwise to a solution of 1 




mixture was quenched by satd NaHCO3, extracted by DCM (100 mL), dried over 
anhydrous Na2SO4 and concentrated. The crude product was purified by chromatography 
column (20:15:3, Hex-DCM–EtOAc) to give 9 (0.61 g, 48.2%) as a glassy solid. m.p. 
138 – 140 °C.  [α]D
21
 = + 120.4 (c = 1.00, CHCl3). Rf = 0.30 (3:1, hexane–EtOAc). 
1
H 
NMR (CDCl3, 500 MHz) δ 8.12 – 7.98 (m, 5H), 7.63 – 7.35 (m, 10H), 5.76 (m, 2H), 5.52 
(d, J = 3.6 Hz, 1H), 4.69 (dd, J = 11.4, 6.2 Hz, 1H), 4.57 (dd, J = 11.4, 6.7 Hz, 1H), 4.44 
(m, 2H), 4.34 (d, J = 2.4 Hz, 2H), 2.35 (t, J = 2.4 Hz, 1H). 
13
C NMR (CDCl3, 125 MHz) 
δ 166.62, 166.20, 165.88, 133.84, 133.55, 133.44, 133.38 130.32, 129.99, 129.93, 129.86, 
129.70, 129.48, 129.38, 128.60, 128.49, 95.70, 78.60, 75.23, 70.83, 68.54 (×2), 68.18, 
63.22, 55.50. HRMS ESI (m/z) (M+Na)
+
 calcd for C30H26O9Na
+
 553.1475, found 
553.1475. 
 
Scheme 3.12 Synthesis of propargyl 6-O-(tert-butyldimethylsilyl)-α-D-galactopyranoside 
25.  
To a cold solution of 1 (3.84 g, 17.61 mmol) in anhydrous pyridine (30 mL), 
imidazole (2.40 g, 35.29 mmol) was added and reaction was stirred until all was 
dissolved. Then, tert-butylchlorodimethylsilane (3.18 g, 21.10 mmol) was added, and the 
mixture was stirred at room temperature for 24 h under nitrogen gas protection. The 
mixture was poured into ice/water. The crystalline precipitate was thoroughly washed 
with cold water and hexane to obtain the product 25 (3.78 g, 64.6%). 
13
C NMR (CD3OD, 




68.54 (C-2 to C-5), 62.23 (C-6), 53.60 (CH2−C≡CH), 24.92 (C(CH3)3), 17.69 (-
C(CH3)3)), -6.59 (2) (-Si(CH3)2). 
 
Scheme 3.13 Synthesis of propargyl 2,3,4-tri-O-benzoyl-6-O-(tert-butyldimethylsilyl)-α-
D-galactopyranoside 10.  
To a solution of 25 (3.21 g, 9.67 mmol) in dry pyridine (40 mL), benzoyl chloride 
(6.74 mL, 58.02 mmol) and a catalytic amount of DMAP was added. The mixture was 
stirred at room temperature for overnight. EtOH (10 mL) was added to quench the 
reaction and the solution was concentrated on high vacuum and diluted by DCM. It was 
washed by 1M HCl (2 x 50 mL) and brine (2 x 60 mL), dried over anhydrous Na2SO4 to 
get the organic layer, which was purified by silica gel chromatography (10:1, hexane–
EtOAc) to give 10 (3.93 g, 63.1%) as colorless syrup. Rf = 0.21 (10:1, hexane–EtOAc) 
1
H 
NMR (CDCl3, 500 MHz):
 
δ 8.09 (m, 2H), 8.00 (m, 2H), 7.81 (m, 2H), 7.61 (m, 1H), 7.50 
(m, 3H), 7.42 (m, 1H), 7.37 (m, 2H), 7.24 (m, 2H), 6.00 (m, 2H), 5.69 (ddd, J = 11.8, 3.8, 
1.6 Hz, 1H), 5.62 (d, J = 3.7 Hz, 1H, H-1), 4.37 (m, 3H), 3.78 (m, 2H), 2.37 (t, J = 2.4 
Hz, 1H, CH2−C≡CH), 0.86 (s, 9H, -C(CH3)3), 0.01, -0.03 (2s, 2×3H, -Si(CH3)2).
 13
C 
NMR (CDCl3, 125 MHz): δ 166.20, 165.63, 165.53 (3×COPh), 133.42, 133.38, 133.12, 
129.97, 129.92, 129.83, 129.75, 129.46, 129.42, 128.69, 128.48, 128.30, 95.30 (C-1), 
78.54 (CH2−C≡CH), 75.19 (CH2−C≡CH), 70.19, 69.33, 69.04, 68.70 (C-2 to C-5), 61.28 
(C-6), 55.30 (CH2−C≡CH), 25.87 (-C(CH3)3), 18.26 (-C(CH3)3)), -5.46, -5.51 (-
Si(CH3)2). MALDI-TOFMS: calcd for C36H40O9Si·Na
+





Scheme 3.14 Synthesis of propargyl 2,3,4-tri-O-benzoyl-α-D-galactopyranoside 11. 
A solution of 10 (3.78 g, 5.87 mmol) and glacial acetic acid (1.00 mL, 17.48 
mmol) in dry THF (20 mL) was treated with 1 M TBAF (11.74 mL, 11.74 mmol) in THF 
at room temperature for overnight. After concentration, the reaction mixture was 
quenched by water, extracted by DCM (300 mL), dried over anhydrous Na2SO4 and 
concentrated. The crude product was purified by chromatography column (30:1, DCM–
EtOAc) to give 11 (2.61 g, 83.8%) as an amorphous white foam. m.p. 59 – 61 °C.  [α]D
21
 
= + 264.3 (c = 1.00, CHCl3). Rf = 0.27 (2:1, hexane–EtOAc). 
1
H NMR (CDCl3, 500 
MHz) δ 8.03 (m, 2H), 7.92 (m, 2H), 7.73 (m, 2H), 7.55 (ddt, J = 8.8, 7.2, 1.3 Hz, 1H), 
7.42 (m, 3H), 7.32 (m, 2H), 7.17 (m, 2H), 5.90 (dd, J = 10.8, 3.4 Hz, 1H), 5.81 (dd, J = 
3.5, 1.1 Hz, 1H), 5.70 (dd, J = 10.7, 3.8 Hz, 1H), 5.53 (d, J = 3.7 Hz, 1H), 4.34 (m, 1H), 
4.28 (dd, J = 2.4, 1.3 Hz, 2H), 3.70 (dt, J = 11.8, 6.9 Hz, 1H), 3.57 (dt, J = 11.8, 6.8 Hz, 
1H), 2.45 (t, J = 7.0 Hz, 1H), 2.31 (t, J = 2.4 Hz, 1H). 
13
C NMR (CDCl3, 125 MHz) δ 
166.87, 166.25, 165.57, 133.91, 133.50, 133.34, 130.16, 130.00, 129.81, 129.34, 129.24, 
129.04, 128.82, 128.55, 128.42, 95.67, 78.56, 75.40, 70.10, 70.00, 69.22, 68.48, 60.88, 
55.77. 
(3) General glycosylation procedure. 
Method A: The galactosyl donor 12 (1.2 equiv) and acceptor (1.0 equiv) were dissolved 
in dry CH2Cl2 (25 mL), followed by adding pre-activated 4 Å molecular sieves powder 




°C and added NIS (2.0 equiv) and TfOH (0.2 equiv) which made a purple solution. After 
the acceptor was completely consumed on TLC analysis, the mixture was filtered through 
Celite, washed with CH2Cl2 for twice, and the combined filtrate was washed with satd 
NaHCO3 aq., satd Na2S2O3 aq. and brine, dried over anhydrous Na2SO4 and concentrated 
in vacuo. 
Method B: A mixture of galactosyl acceptor (1.0 equiv) and activated 4Å molecular 
sieves in CH2Cl2 (0.05 M) was stirred for 1 h under nitrogen at room temperature, 
followed by cooled to -20 °C and the addition of NIS (2.0 equiv) and TfOH (0.2 equiv). 
A solution of thiophenol donor 12 (1.2 equiv) in CH2Cl2 (0.25 M) was added dropwise to 
the reaction mixture. After stirring for 30 min, the reaction mixture was warmed to room 
temperature. When the acceptor was completely consumed on TLC analysis, the mixture 
was filtered through Celite, washed with CH2Cl2 for twice, and the combined filtrate was 
washed with satd NaHCO3 aq., satd Na2S2O3 aq. and brine, dried over anhydrous Na2SO4 
and concentrated in vacuo. 
(4) General procedure for di-tert-butylsilylidene group removal. 
A solution of saccharide (1 equiv) and glacial acetic acid (7 equiv) in dry THF 
(10.0 mL) was treated with 1 M tetrabutylammonium fluoride (TBAF) (10 equiv) in THF 
at room temperature for overnight. After concentration, the reaction mixture was 
quenched by water, extracted by DCM (100 mL), dried over anhydrous Na2SO4 and 
concentrated. 
(5) General procedure for debenzoylation. 
Benzoylated saccharide was dissolved in dry MeOH (20 mL), followed by adding 






 IR 120 (H
+
). The resin was filtered off and the solvent was 
removed in vacuo. 
 
Scheme 3.15 Synthesis of propargyl 3-O-benzoyl-4,6-di-O-tert-butylsilanediyl-2-O-(2,3-
di-O-benzoyl-4,6-di-O-tert-butylsilanediyl-α-D-galactopyranosyl)-α-D-galactopyranoside 
13.  
Compound 13 was synthesized according to the general glycosylation method B 
above. The crude product was purified by silica gel chromatography (20:3:1, hexane–
CH2Cl2–EtOAc) to give 13 (238 mg, 58.3 %) as a white amorphous foam. Rf = 0.42 
(10:3:1, hexane–CH2Cl2–EtOAc). [α]D
21
 = +190.9 (c = 1.00, CHCl3). 
1
H NMR (600 
MHz, Chloroform-d) δ 8.06 (m, 4H, Ar-H), 7.96 (m, 2H, Ar-H), 7.59 (m, 1H, Ar-H), 7.54 
– 7.47 (m, 4H, Ar-H), 7.42 – 7.34 (m, 4H, Ar-H), 5.65 (dd, J = 10.5, 3.6 Hz, 1H, H-2’), 
5.50 (d, J = 3.8 Hz, 1H, H-1’), 5.48 (m, 1H, H-3’), 5.42 (dd, J = 10.3, 3.2 Hz, 1H, H-3), 
5.12 (d, J = 3.6 Hz, 1H, H-1), 4.76 (dd, J = 3.3, 1.1 Hz, 1H, H-4), 4.64 (dd, J = 3.1, 1.1 
Hz, 1H, H-4’), 4.43 (dd, J = 10.3, 3.6 Hz, 1H, H-2), 4.25 (dd, J = 12.7, 2.2 Hz, 1H, H-
6a/b), 4.14 (dd, J = 12.7, 1.7 Hz, 1H, H-6a/b), 4.05 (dd, J = 12.5, 1.5 Hz, 1H, H-6’a/b), 3.96 




Hz, 1H, CH2−C≡CH), 1.04, 1.02, 0.92, 0.87 (4s, 36H, 4 CH3-tBu-Si). 
13
C NMR (151 MHz, 
Chloroform-d) δ 166.42, 166.22, 166.06 (3 C=OBz), 133.42, 133.30, 133.13, 130.54, 
130.07, 129.78, 129.64, 129.62, 128.66, 128.57, 128.44, (Ar-C), 96.15 (C-1), 95.78 (C-
1’), 78.88 (CH2−C≡CH), 74.79 (CH2−C≡CH), 72.02 (C-3), 71.50 (C-2), 71.05 (C-4), 
71.01 (C-3’), 70.92 (C-4’), 69.04 (C-2’), 67.40 (C-5), 67.27 (C-5’), 66.96 (C-6’), 66.82 
(C-6), 55.32 (CH2−C≡CH), 27.59, 27.56, 27.35, 27.34 (4 CH3-tBu-Si), 23.36, 23.31, 20.80, 
20.79 (4 Cq-tBu-Si). MALDI-TOFMS: calcd for C52H68O14Si2·Na
+
: 995.4040; found: m/z 
995.4038. 
 
Scheme 3.16 Synthesis of propargyl 2-O-(α-D-galactopyranosyl)-α-D-galactopyranoside 
2.  
The crude product was purified by silica gel chromatography (4:1, EtOAc–
MeOH) to give 2 as a white powdery solid (49 mg, 84.2 %). Rf = 0.44 (1:1, EtOAc–
MeOH). [α]D
20
 = 84.0 (c = 1.00, CH3OH). 
1
H NMR (600 MHz, Methanol-d4) δ 5.31 (d, J 
= 3.7 Hz, 1H, H-1), 5.11 (d, J = 3.8 Hz, 1H, H-1’), 4.37 (t, J = 2.2 Hz, 2H, CH2−C≡CH), 
4.18 (m, 1H, H-5’), 4.07 (dd, J = 10.1, 3.7 Hz, 1H, H-2), 4.00 (m, 1H, H-4), 3.96 (dd, J = 




3’), 3.83 – 3.74 (m, 5H, H-6a,b, H-2’, H-6’a,b) 2.92 (t, J = 2.4 Hz, 1H, CH2−C≡CH). 
13
C 
NMR (151 MHz, Methanol-d4) δ 98.08 (C-1’), 96.13 (C-1), 80.00 (CH2−C≡CH), 76.28 
(CH2−C≡CH), 74.25 (C-2), 72.76 (C-5), 72.53 (C-5’), 71.47 (C-3’), 71.17 (C-4’), 71.13 
(C-4), 70.33 (C-2’), 69.76 (C-3), 62.90 (C-6’), 62.61 (C-6), 55.34 (CH2−C≡CH). HRMS 
ESI (m/z) (M+Na)
+
 calcd for C15H24O11Na
+
 403.1216, found 403.1218. 
 
Scheme 3.17 Synthesis of propargyl 2-O-benzoyl-4,6-di-O-acetyl-3-O-(2,3-di-O-
benzoyl-4,6-di-O-acetyl-α-D-galactopyranosyl)-α-D-galactopyranoside 26.  
Compound 14 was synthesized according to the general glycosylation method B 
above. After removal the di-tert-butylsilylidene group, the reaction mixture was dissolved 
in dry pyridine (10 mL), followed by adding acetic anhydride (6 equiv) and a catalytic 
amount of DMAP. The mixture was stirred at room temperature for overnight. Toluene 
(3×25 mL) was added and the solution was concentrated, and it was extracted with 
CH2Cl2 (150 mL) and satd NaHCO3 aq. The organic layer was then separated and washed 




was purified by silica gel chromatography (3:1, hexane–EtOAc) to give 26 (621 mg, 79.4 
%) as a white crystal. m.p. 148 – 150 °C. Rf = 0.36 (1.5:1, hexane–EtOAc). [α]D
20
 = 
+234.6 (c = 1.00, CHCl3). 
1
H NMR (500 MHz, Chloroform-d) δ 8.12 (m, 2H), 7.97 (m, 
2H), 7.78 (m, 2H), 7.62 (m, 1H), 7.51 – 7.27 (m, 8H), 5.61 (dd, J = 10.9, 3.5 Hz, 1H, H-
2’), 5.55 – 5.47 (m, 4H, H-2, H-4, H-1’, H-3’), 5.39 (d, J = 3.8 Hz, 1H, H-1), 5.24 (dd, J 
= 3.4, 1.3 Hz, 1H, H-4’), 4.55 (dd, J = 10.7, 3.1 Hz, 1H, H-3), 4.44 (ddd, J = 7.7, 4.9, 1.4 
Hz, 1H, H-5’), 4.25 (d, J = 2.5 Hz, 2H, CH2−C≡CH), 4.23 (m, 1H, H-5), 4.13 – 4.01 (m, 
4H, H-6a,b, H-6’a,b), 2.32 (t, J = 2.3 Hz, 1H, CH2−C≡CH), 2.11, 2.08, 2.02, 1.36 (4s, 12H, 
4×COCH3). 
13
C NMR (126 MHz, Chloroform-d) δ 170.46, 170.45, 169.94, 169.92 (4 
C=OAc), 166.02, 165.91, 165.12 (3 C=OBz), 133.74, 133.33, 133.27, 130.05, 129.77, 
129.64, 129.61, 129.52, 129.23, 128.77, 128.45, 128.44 (Ar-C), 95.68 (C-1), 92.57 (C-
1’), 78.47 (CH2−C≡CH), 75.26 (CH2−C≡CH), 69.15 (C-2), 68.63 (C-3), 68.36 (C-4’), 
67.86 (C-2’), 67.72 (C-3’), 67.23 (C-5), 67.20 (C-5’), 65.42 (C-4), 62.23 (C-6’), 61.69 
(C-6), 55.67 (CH2−C≡CH), 20.87, 20.83, 20.66, 19.64 (4×COCH3). MALDI-TOFMS: 
calcd for C44H44O18·Na
+
: 883.2420; found: m/z 883.2423. 
 
Scheme 3.18 Synthesis of propargyl 3-O-(α-D-galactopyranosyl)-α-D-galactopyranoside 
3.  
The crude product was purified by silica gel chromatography (4:1, EtOAc–






 = 265.8 (c = 1.00, CH3OH). 
1
H NMR (600 MHz, Deuterium oxide) δ 5.18 
(d, J = 3.6 Hz, 1H, H-1), 5.17 (d, J = 3.9 Hz, 1H, H-1’), 4.37 (m, 2H, CH2−C≡CH), 4.27 
(m, 1H, H-4), 4.19 (m, 1H, H-5’), 4.04 – 3.95 (m, 5H, H-2, H-3, H-5, H-3’, H-4’), 3.88 
(dd, J = 10.4, 3.9 Hz, 1H, H-2’), 3.79 – 3.75 (m, 4H, H-6a,b, H-6’a,b), 2.92 (t, J = 2.4 Hz, 
1H, CH2−C≡CH). 
13
C NMR (126 MHz, Deuterium oxide) δ 97.16 (C-1), 94.94 (C-1’), 
78.90 (CH2−C≡CH), 75.90 (CH2−C≡CH), 74.03 (C-2), 70.99 (C-3’), 70.82 (C-5’), 69.22 
(C-3), 69.12 (C-4’), 68.13 (C-2’), 66.28 (C-5), 65.29 (C-4), 60.95 (C-6’), 60.89 (C-6), 
54.71 (CH2−C≡CH). HRMS ESI (m/z) (M+Na)
+





Scheme 3.19 Synthesis of propargyl 2,3,6-tri-O-benzoyl-4-O-(2,3-di-O-benzoyl-4,6-O-
di-tert-butyl-silanediyl-α-D-galactopyranosyl)-α-D-galactopyranoside 15.  
Compound 15 was synthesized according to the general glycosylation method B 
above. The crude product was purified by silica gel chromatography (10:1, hexane–
EtOAc) to give 15 (693 mg, 52.9 %) as a white amorphous foam. Rf = 0.46 (3:1, hexane–
EtOAc). [α]D
21
 = +207.4 (c = 1.00, CHCl3). 
1
H NMR (500 MHz, Chloroform-d) δ 8.06 – 
7.98 (m, 8H), 7.87 – 7.85 (m, 2H), 7.56 – 7.49 (m, 4H), 7.42 – 7.35 (m, 9H), 7.30 (m, 




Hz, 1H, H-3’), 5.51 (d, J = 3.7 Hz, 1H, H-1’), 5.48 (d, J = 3.6 Hz, 1H, H-1), 4.94 (dd, J = 
3.1, 1.1 Hz, 1H, H-4’), 4.68 (dd, J = 10.7, 6.3 Hz, 1H, H-6a), 4.48 (m, 1H, H-4), 4.38 (m, 
1H, H-5), 4.34 – 4.31 (m, 4H, H-5’, H-6b, CH2−C≡CH), 3.84 (qd, J = 12.9, 1.9 Hz, 2H, 
H-6’a,b), 2.35 (t, J = 2.4 Hz, 1H, CH2−C≡CH), 1.08 (s, 9H, CH3-tBu-Si), 0.93 (s, 9H, CH3-
tBu-Si). 
13
C NMR (126 MHz, Chloroform-d) δ 166.40, 166.27, 166.15, 166.05, 165.67 (5 
C=OBz), 133.66, 133.45, 133.40, 133.25, 133.20, 130.07, 130.01, 129.99, 129.98, 129.85, 
129.76, 129.52, 129.40, 129.34, 129.07, 128.75, 128.59, 128.49, 128.48 (×2) (Ar-C), 
98.73 (C-1’), 95.84 (C-1), 78.58 (CH2−C≡CH), 76.54 (C-4), 75.27 (CH2−C≡CH), 71.37 
(C-4’), 71.02 (C-3’), 70.19 (C-2), 69.11 (C-2’), 69.04 (C-5), 68.37 (C-3), 68.15 (C-5’), 
66.74 (C-6’), 61.87 (C-6), 55.50 (CH2−C≡CH), 27.60, 27.36 (2 CH3-tBu-Si), 23.35 (Cq-
tBuSi), 20.85 (Cq-tBuSi). MALDI-TOFMS: calcd for C58H60O16Si·Na
+
: 1063.3543; found: 
m/z 1063.3543. 
 
Scheme 3.20 Synthesis of propargyl 4-O-(α-D-galactopyranosyl)-α-D-galactopyranoside 
4.  
The crude product was purified by silica gel chromatography (4:1, EtOAc–
MeOH) to give 4 as a white powdery solid (163 mg, 84.0 %). Rf = 0.50 (1:1, EtOAc–
MeOH). [α]D
20
 = 183.9 (c = 1.00, CH3OH). 
1




J = 3.7 Hz, 1H, H-1), 4.99 (d, J = 3.8 Hz, 1H, H-1’), 4.30 (dd, J = 2.5, 0.9 Hz, 2H, 
CH2−C≡CH), 4.21 (ddd, J = 6.8, 5.1, 1.3 Hz, 1H, H-5’), 4.06 (m, 1H, H-4), 3.92 (m, 2H, 
H-4’, H-5), 3.86 – 3.68 (m, 8H, H-2, H-3, H-6a,b, H-2’, H-3’, H-6’a,b), 2.88 (t, J = 2.4 Hz, 
1H, CH2−C≡CH). 
13
C NMR (126 MHz, Methanol-d4) δ 102.75 (C-1’), 99.16 (C-1), 
81.18 (C-4), 80.15 (CH2−C≡CH), 76.07 (CH2−C≡CH), 73.01 (C-5’), 72.39 (C-5), 71.18 
(C-2’), 71.12 (C-2), 70.96 (C-4’), 70.49 (C-3), 70.30 (C-3’), 62.66 (C-6’), 61.40 (C-6), 
55.66 (CH2−C≡CH). HRMS ESI (m/z) (M+Na)
+





Scheme 3.21 Synthesis of propargyl 2,3,4-tri-O-benzoyl-6-O-(2,3-di-O-benzoyl-4,6-O-
di-tert-butyl-silanediyl-α-D-galactopyranosyl)-α-D-galactopyranoside 16.  
Compound 16 was synthesized according to the general glycosylation method A 
above. The crude product was purified by silica gel chromatography (16:3:1, hexane–
DCM–EtOAc) to give 16 (2.64 g, 64.0 %) as an amorphous white foam. Rf = 0.33 (4:1, 
hexane–EtOAc). m.p. 106 – 108 °C. [α]D
21
 = +233.6 (c = 1.00, CHCl3). 
1
H NMR (500 
MHz, Chloroform-d) δ 8.03 – 7.98 (m, 7H), 7.76 (dd, J = 8.3, 1.4 Hz, 2H), 7.60 (m, 1H), 
7.52 – 7.36 (m, 13H), 7.22 (m, 2H), 5.94 (dd, J = 10.6, 3.4 Hz, 1H), 5.89 (dd, J = 3.4, 1.3 




Hz, 1H), 5.58 (dd, J = 10.6, 3.1 Hz, 1H), 5.27 (d, J = 3.6 Hz, 1H), 4.90 (dd, J = 3.1, 1.1 
Hz, 1H), 4.53 (ddd, J = 7.3, 4.6, 1.3 Hz, 1H), 4.39 – 4.31 (m, 3H), 4.27 (dd, J = 12.7, 1.7 
Hz, 1H), 4.08 – 4.07 (m, 1H), 3.89 (dd, J = 10.7, 7.5 Hz, 1H), 3.69 (dd, J = 10.7, 4.4 Hz, 
1H), 2.44 (t, J = 2.4 Hz, 1H), 1.12 (s, 9H), 0.98 (s, 9H). 
13
C NMR (126 MHz, 
Chloroform-d) δ 166.31, 166.22, 166.20, 165.54, 165.53 (5 C=OBz), 133.66, 133.47, 
133.31, 133.22, 133.19, 130.05, 130.04, 130.01, 129.94, 129.85, 129.81, 129.62, 129.38, 
129.30, 129.24, 128.75, 128.54, 128.53, 128.48, 128.34 (Ar-C), 97.08, 95.32 (C-1 and C-
1’), 78.47, 75.56, 71.34, 71.06, 69.63, 69.07, 68.74, 68.62, 68.49, 67.46, 67.14, 67.07, 
55.52 (CH2−C≡CH), 27.68, 27.39 (2 CH3-tBu-Si), 23.45 (Cq-tBuSi), 20.87 (Cq-tBuSi). 
MALDI-TOFMS: calcd for C58H60O16Si·Na
+
: 1063.3543; found: m/z 1063.3543. 
 
Scheme 3.22 Synthesis of propargyl 2,3,4-tri-O-benzoyl-6-O-(2,3-di-O-benzoyl-α-D-
galactopyranosyl)-α-D-galactopyranoside 27.  
The crude product was purified by chromatography column (5:1, DCM–EtOAc) 
to give 27 (1.90 g, 91.5 %) as an amorphous white foam. m.p. 102 – 104 °C. [α]D
21
 = + 
237.4 (c = 1.00, CHCl3). Rf = 0.36 (1:1.5, hexane–EtOAc).
 1
H NMR (500 MHz, 
Chloroform-d) δ 8.02 – 7.94 (m, 7H), 7.75 (m, 2H), 7.59 (m, 1H), 7.52 – 7.32 (m, 13H), 




Hz, 1H), 4.58 (ddd, J = 6.8, 5.5, 1.3 Hz, 1H), 4.49 (td, J = 2.7, 1.2 Hz, 1H), 4.41 – 4.31 
(qd, J = 16.0, 2.4 Hz, 2H), 4.21 (td, J = 4.7, 1.4 Hz, 1H), 4.03 – 3.95 (m, 1H), 3.89 (dd, J 
= 10.7, 7.0 Hz, 1H), 3.72 (dd, J = 10.7, 5.4 Hz, 1H), 3.11(d, J = 3.0 Hz, 1H), 2.55 (m, 
1H), 2.49 (t, J = 2.4 Hz, 1H). 
13
C NMR (126 MHz, Chloroform-d) δ 166.26, 166.18, 
165.86, 165.65, 165.56 (5 C=OBz), 133.63, 133.46, 133.43, 133.31, 133.23, 130.03, 
129.99, 129.94, 129.91, 129.80, 129.51, 129.44, 129.34, 129.26, 129.22, 128.74, 128.55, 
128.51, 128.50, 128.32 (Ar-C), 97.31, 95.63 (C-1 and C-1’), 78.58, 77.41, 77.16, 76.91, 
75.62, 71.11, 69.80, 69.79, 69.46, 69.05, 68.76, 68.61, 68.48, 67.23, 63.26, 
55.77(CH2−C≡CH). MALDI-TOFMS: calcd for C50H44O16·Na
+
: 923.2522; found: m/z 
923.2526. 
 
Scheme 3.23 Synthesis of propargyl 6-O-(α-D-galactopyranosyl)-α-D-galactopyranoside 
5.  
The crude product was purified by chromatography column (4:1, EtOAc–MeOH) 
to give 5 (543 mg, 80.4%) as a white powdery solid. Rf = 0.43 (1:1, EtOAc–MeOH). 
[α]D
20
 = + 160.6 (c = 1.00, CH3OH). 
1
H NMR (500 MHz, Methanol-d4) δ 5.03 (d, J = 3.8 
Hz, 1H, H-1), 4.87 (d, J = 3.7 Hz, 1H, H-1’), 4.29 (t, J = 2.4 Hz, 2H, CH2−C≡CH), 4.00 
(m, 1H, H-5), 3.96 (dd, J = 3.3, 1.2 Hz, 1H, H-4), 3.91 – 3.85 (m, 3H, H-4’, H-5’, H-6a), 




H-6b), 2.89 (t, J = 2.4 Hz, 1H, CH2−C≡CH). 
13
C NMR (126 MHz, Methanol-d4) δ 
100.33 (C-1’), 98.89 (C-1), 80.13 (CH2−C≡CH), 76.17 (CH2−C≡CH), 72.39 (C-5’), 
71.51 (C-3’), 71.25 (C-2’), 71.09 (C-4’), 70.76 (C-4), 70.66 (C-5), 70.19 (C-3), 69.98 (C-
2), 67.62 (C-6), 62.71 (C-6’), 55.46 (CH2−C≡CH). HRMS ESI (m/z) (M+Na)
+
 calcd for 
C15H24O11Na
+
 403.1216, found 403.1216. 
 





Compound 19 was synthesized according to the general glycosylation method A 
above. The crude product was purified by silica gel chromatography (4:1, hexane–
EtOAc). It was deprotected, acetylated, and purified again by silica gel chromatography 
(1:1.5, hexane–EtOAc) to give 19 (153 mg, 42.8%) as colorless oil. Rf = 0.29 (1:1.5, 
hexane–EtOAc). [α]D
21
 = 165.7 (c = 1.00, CHCl3). 
1
H NMR (600 MHz, Chloroform-d) δ 
5.51 – 5.45 (m, 3H, H-3, H-4’’, H-4’), 5.34 (dd, J = 10.9, 3.3 Hz, 1H, H-3’), 5.28 (m, 1H, 
H-3’’), 5.26 (d, J = 3.8 Hz, 1H, H-1), 5.16 (d, J = 3.5 Hz, 1H, H-1’), 5.14 – 5.12 (m, 2H, 




(dd, J = 10.3, 3.7 Hz, 1H, H-2), 4.31 – 4.25 (m, 4H, CH2−C≡CH, H-5’’, H-5’), 4.19 (dd, 
J = 11.3, 5.6 Hz, 1H, H-6’’a/b), 4.07 – 4.01 (m, 2H, H-5, H-6’’a/b), 3.75 (dd, J = 11.5, 5.2 
Hz, 1H, H-6a/b), 3.70 (dd, J = 10.1, 6.4 Hz, 1H, H-6’a/b), 3.58 (dd, J = 11.4, 2.3 Hz, 1H, 
H-6a/b), 3.40 (dd, J = 10.1, 6.0 Hz, 1H, H-6’a/b), 2.57 (t, J = 2.4 Hz, 1H, CH2−C≡CH), 
2.13 (×2), 2.11, 2.07 (×3), 2.05, 2.01, 1.97(×2) (10×COCH3). 
13
C NMR (151 MHz, 
Chloroform-d) δ 170.70, 170.65, 170.60, 170.31, 170.25, 170.22, 170.16, 169.97, 169.93, 
169.65 (10× C=OAc), 96.36 (C-1’), 96.23 (C-1’’), 94.42 (C-1), 78.35 (CH2−C≡CH), 
75.76 (CH2−C≡CH), 70.57 (C-2), 70.18 (C-3), 69.12 (C-5), 68.97 (C-4), 68.57 (C-4’), 
68.34 (C-4’’), 68.23 (C-2’), 67.78 (C-3’), 67.75 (C-2’’), 67.48 (C-3’’), 67.32 (C-5’), 
66.77 (C-5’’), 66.21 (C-6), 65.88 (C-6’), 62.11 (C-6’’), 55.45 (CH2−C≡CH), 20.96, 
20.86 (×2), 20.82 (×3), 20.79, 20.77, 20.76, 20.74 (10×COCH3). MALDI-TOFMS: calcd 
for C41H54O26·Na
+
: 985.2796; found: m/z 985.2798. 
 
 





The crude product was purified by chromatography column (1:1, EtOAc–MeOH) 
to give 6 (48 mg, 84.9%) as a white powdery solid. Rf = 0.5 (MeOH). [α]D
21
 = 154.2 (c = 
1.00, CH3OH). 
1
H NMR (600 MHz, Deuterium Oxide) δ 5.13 (d, J = 3.8 Hz, 1H, H-1), 
4.99 (2d, J = 3.6 Hz, 2H, H-1’, H-1’’), 4.37 (m, 2H, CH2−C≡CH), 4.19 (m, 1H, H-5’), 
4.04 (m, 1H, H-4’), 4.01 – 3.98 (m, 3H, H-4, H-4’’, H-6a/b), 3.91 – 3.81 (m, 6H, H-3’, H-
3, H-6’a/b, H-3’’, H-2’, H-2’’), 3.75 – 3.67 (m, 5H, H-6’’a,b, H-6a/b, H-6’a/b, H-5), 3.62 (m, 
1H, H-2), 3.53  (m, 1H, H-5’’), 2.92 (m, 1H, CH2−C≡CH). 
13
C NMR (151 MHz, 
Deuterium oxide) δ 97.92 (C-1’’, JC1’’-H1’’ = 170.55 Hz), 97.81 (C-1’, JC1’-H1’ = 169.56 
Hz), 97.00 (C-1, JC1-H1 = 170.92 Hz), 78.73 (CH2−C≡CH), 76.00 (CH2−C≡CH), 73.16 
(C-5), 70.89 (C-4), 70.83 (C-2), 70.56 (C-3), 69.41 (C-3’’), 69.38 (C-5’’), 69.33 (C-3’), 
69.25 (C-4’), 69.14 (C-4’’), 68.68 (C-5’), 68.29 (C-2’’), 68.19 (C-2’), 66.36 (C-6’), 65.26 
(C-6), 61.05 (C-6’’), 54.84 (CH2−C≡CH). HRMS ESI (m/z) (M+Na)
+
 calcd for 
C21H34O16Na
+
 565.1745, found 565.1748. 
3.3 Conclusions 
I have described straightforward syntheses of α-linked propargyl terminated 
galactosides with various spatial presentations. Flexible and efficient regioselective 
protection strategies were performed on propargyl galactoside to give the corresponding 
glycosyl acceptors. The high α-stereoselective glycosylations were accomplished with the 
usage of 4,6-di-tert-butylsilylene protected thiogalactoside donor. After mild deprotection 
sequences, the desired galactoside ligands were obtained in satisfied yield, and their 




C NMR, 2D NMR, and 
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Chapter 4 Construction of an α-Galactosides Featured 




















A synthetic carbohydrate microarray with the immobilization of a collection of 
diversely presented galactoside clusters was constructed to imitate featured carbohydrate 
presentations on natural cell surface. The synthetic surface was interrogated by a 
fluorescence-labeled lectin to quantitatively analyze their binding affinities and 
dissociation constants. The lectin showed stronger binding affinities with disaccharides 
that possess the non-reducing terminal Gal-α-(1,3)-Gal, Gal-α-(1,4)-Gal and Gal-α-(1,6)-
Gal aglycones. This study will add new dimensions to our understanding of the effects of 
spatial arrangement of carbohydrate ligands in carbohydrate–lectin binding, and shed 


















The glycocalyx, which is the thick layer of glycoconjugates covering both 
eukaryotic and prokaryotic cell membrane surfaces, forms the basis for molecular 
recognitions. Its interactions with lectins have been recognized to be critical in mediating 
biological activities such as cell–cell communication and adhesion, host–pathogen 
interactions and immune defense.
1
 However, understanding the mechanism of 
carbohydrates–lectin interactions is arduous.
2
 A major impediment is the complex 
structure of carbohydrates, which makes both chemical synthesis of the oligosaccharide 
structures involved and biochemical analysis of their interactions with recognition 
proteins highly challenging. Carbohydrate structures display tremendous diversity and 
informational storage capacity because many permutations of size, composition, 
connectivity, and spatial arrangement can be generated. Moreover, the multimeric 
architecture of lectins allows simultaneous binding to multiple carbohydrate ligands to 
generate multivalent binding types, while proper presentation of the carbohydrate ligands 
with matched spacing and orientation is necessary.
3, 4
  
In order to systematically investigate the molecular basis of carbohydrate–lectin 
interactions, carbohydrate microarrays have been developed as an imitation of natural 
glycosylated surfaces.
5
 Synthetic carbohydrate ligands, which can be acquired in 
sufficient amount and high purity, are made and immobilized on solid supports with a 
linker incorporated.
6
 Several carbohydrate microarrays have been constructed by 







 and glycoclusters with different valency,
10
 to 





yet, less emphasis has been put on the integration of spatial and chemical patterning of 
the synthetic glycan surface.
12
  
Herein, I report a modular approach to constructing carbohydrate microarray by 
immobilizing various α-linked galactoside clusters to investigate the influence of spatial 
organization and site-specific ligand modifications on the recognition and binding with 
lectin. The synthesized α-linked galactoside ligands 16 (Figure 3.1) were coupled with 
the azido-PEG-biotin linker by click chemistry to afford the glycoconjugates G1–G6, 
respectively, which were immobilized to an avidin-coated glass slide to afford the 
carbohydrate microarray at defined densities. The synthetic carbohydrate landscape was 
interrogated by using fluorescence imaging technique to assess the recognition with 
Griffonia Simplicifolia Lectin I-isolectin B4 (GSL I-B4), a C-type lectin that shows high 
affinity to α-D-galactosyl end groups.
13–15
 C-Type lectins are Ca
2+
-dependent glycan-
binding proteins, and the binding occurs primarily through the coordination of the 
calcium ion with the specific amino acid residues and the 3- and 4-hydroxyl groups on 
the sugar.
16
 Because the protein and sugar are insulated by the calcium ion, recognition is 
somewhat loose and primarily involves a single sugar unit. Sugars can be recognized in 
alternative orientations, and structurally related sugars can be recognized.
17, 18
 Thus, how 
strongly a particular biological surface is recognized depends heavily on presentation, the 
subtleties of which the present work specifically seeks to explore. 
4.2 Construction of Carbohydrate Microarray 
The synthesized α-galactoside ligands 16 were used directly for the construction 








Figure 4.1 Landscape of synthetic α-linked galactosides microarray and its 
















primarily the geometry of the lectin multimers, the need for structures that have good 
water solubility and resistance to non-specific protein adsorption, and the desire to use 
readily available azide derivatives that can be incorporated readily into the modular 
architecture. It is expected that substantially long length of linkers may be needed, as the 
linear path between binding sites is not physically possible with a short linker, and some 
added flexibility will be helpful in facilitating proper orientation of the terminal sugar 
residues. Therefore, azido-PEG-biotin linker, derived from polyethylene glycol (PEG), 
was synthesized
19
 and used, which is hydrophilic and highly flexible. It was coupled with 
propargyl α-D-galactosides 1–6 by Cu-catalyzed azide–alkyne 1,3-dipolar cycloaddition  
(CuAAC) “click chemistry”
20
 to synthesize the glycoconjugates G1–G6 (Scheme 4.1).  
 
Scheme 4.1 Conjugation of propargyl terminated galactosides with azido-PEG-biotin 
linker yielded glycoconjugates G1–G6 primed with a biotin group for immobilization on 
avidin-coated slides. Reagents and conditions: (a) CuSO4, Sodium ascorbate, THTPA.  
The resulting glycoconjugates were printed at 12 concentrations (1 M – 100 M, 
by glycan) on avidin-coated glass slides using a robotic spotter to afford microarrays with 
increasing glycoconjugates densities. Each concentration was spotted as four replicate 




grids allowed for the systematic modification of both sugar and protein concentrations. 
The microarray slides were incubated overnight in a humid chamber at 55 °C to allow 
biotin–avidin binding to proceed. After washing to remove unbound glycans, the 
microarray slides were incubated with DyLight 594-labeled GSL I-B4 lectin, and 
visualized using a fluorescence scanner (Figure 4.2a). 
The binding curves (Figure 4.2b) were plotted from the surface bound 
glycoconjugates G1–G6, showing the fluorescence resulting from the bound lectin as a 
function of the concentration of GSL I-B4 lectin that was incubated with the slide.
21
 It 
shows that the all of the arrayed glycoconjugates G1–G6 were recognized by the GSL I-
B4 lectin, while their affinities varied depending on the glycoconjugate structure. G3–G5 
showed stronger bindings than G1, G2, and G6. The dissociation constants (Kd) of each 
glycoconjugate were also determined to add more quantitative insights (Table 4.1). G3 
and G5 exhibited lower Kd values (58.9 nM and 59.5 nM, respectively) and higher 
binding affinities, which is followed by G4 (67.2 nM); while G1, G2 and G6 displayed 
higher Kd values (82.5 nM, 83.6 nM and 100.3 nM, respctively) and lower binding 
affinities. It indicated that the disaccharides showed generally better binding affinities 
than the monosaccharide and the trisaccharide. I surmise that it may be due to the less 
binding sites (hydroxyl groups) of monosaccharide than disaccharide, and the bulky size 
of trisaccharide that limits lectin’s accessibility. G2 possessing an terminus Gal-α-(1,2)-
Gal disaccharide, unexpectedly, showed low binding affinity. A mechanistic explanation 
of it is no doubt complicated, as many factors are possible and difficult to sort out. 
Perhaps noteworthy is the downward orientation fact of the terminal α-Gal, which is to 
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(c) 
Figure 4.2 (a) Fluorescence scanning of carbohydrate microarray after DyLight 594-
labeled GSL I-B4 lectin incubation (Cglycan = 1 μM to 100 μM); (b) Binding curves 
obtained from the surface bound glycoconjugates G1–G6 as a function of GSL I-B4 lectin 











Glycoconjugates Kd (nM) Error (%) Glycoconjugates Kd (nM) Error (%) 
G1 82.5 6.6 G4 67.2 8.2 
G2 83.6 5.9 G5 59.5 8.9 




Table 4.2 Relationship of different printing concentrations of G3 and the dissociation 













100 58.9 9.1 10 61.6 4.2 
80 72.9 6.5 5 104.4 7.7 
40 65.0 4.1 2 217.4 18.6 










The binding curves of the glycocluster G3 at different concentrations were plotted 
as well to further explore the relationship between ligand concentration with lectin-
binding affinity (Figure 3(c)). Eight binding curves were plotted representing eight 
printing concentrations of G3 (100 μM, 80 μM, 40 μM, 20 μM, 10 μM, 5 μM, 2 μM, 1 
μM, respectively). When the printing concentrations of G3 were within 100 to 10 μM, the 
Kd values obtained are narrowly distributed (mean Kd = 64 nM; SD = 5.4 nM; Table 4.2). 
However, when the printing concentrations were below 10 μM, the Kd values increase 
and the binding affinities decrease. This is probably due to the increased distance 
between the ligands on the surface. If the distance between G3 ligands on the surface is 
close enough, a multivalent binding type with GSL I-B4 lectin will form. However, if the 
printing concentration is below 10 μM, the average distance between immobilized G3 
ligand is too far for a multivalent interaction with the lectin. 
4.3 Experimental Section 
4.3.1 General procedure for glycoconjugates G1−G6 synthesis 
Stock solutions were prepared as follows: six propargyl-terminated saccharides 
1−6 in water (10 mM, respectively); azido-PEG-biotin linker in water (10 mM); CuSO4 
in water (50 mM); sodium ascorbate in water (250 mM); THPTA (tris(3-
hydroxypropyltriazolylmethyl)amine) in PBS buffer (1 M, pH 7, 0.5 % DMSO).  
Solutions were added to six Eppendorf tubes (respectively with six 
glycoconjugates) in the following order (vortex after adding each solution): 850 μL PBS, 
10 μL saccharide, 10 μL azido-PEG-biotin linker, 10 μL CuSO4, 110 μL THPTA, and 10 




solutions were then diluted to 12 concentrations ranged from 1 μM to 100 μM, and 
printed on to streptavidin-coated slides. 
4.3.2 Preparation of microarrays  
For microarray experiments, all water used was obtained from a Milli-Q water 
purification system (Millipore). Six glycoclusters with biotin linkers in phosphate-
buffered saline (PBS) buffer (1x PBS, pH 7.4 and 0.05% Tween-20) were immobilized at 
12 concentrations (1 M – 100 M, by glycan) on streptavidin-coated glass (SuperAvidin 
Microarray Substrates, ArrayIt®). Each concentration was spotted as four replicate spots, 
and four replicate super grids were printed for each glycocluster. The printed slides were 
incubated overnight in a humid chamber at 55 °C. The slides were rinsed with PBS buffer 
(1XPBS, pH 7.4 and 0.05% Tween-20, 3 x 5 min), blocked in Superblock solution 
(ArrayIt®) for 1 h on shaker, washed in PBS (3 x 5 min) again, and dried over a flow of 
nitrogen. 
4.3.3 Microarray–lectin binding assay  
DyLight® 594 Griffonia Simplicifolia Lectin I (GSL I) – Isolectin B4 lectin 
(DyLight® 594 GSL I – B4 Lectin, Vector Lab) was diluted to 2, 5, 10, 20, 50, and 80 
g/mL, respectively, in PBS (1x PBS, 0.05% Tween-20, 0.15 M NaCl), and incubated 
with six printed carbohydrate microarray slides, correspondingly. Slides were incubated 
in a humid chamber for 3 h at room temperature, rinsed with PBS (1XPBS, pH 7.4 and 
0.05% Tween-20, 3 x 5 min), water (3 x 5 min), and dried over a flow of nitrogen. The 
slides were scanned with a GenePix 4300A microarray scanner (Molecular Devices, 
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Figure 4.3 Scanned images of GSI B4 lectin–incubated carbohydrate slides. Lectin 
concentrations: (a) 2 g/mL, (b) 5 g/mL, (c) 10 g/mL, (d) 20 g/mL, (e) 50 g/mL, (f) 
80 g/mL. The two columns on right side in (d) and (f) were not included in the Kd 




4.3.4 Calculation of Kd 
Slides were scanned at 532 nm then at 635 nm with the microarray scanner. 
Fluorescence intensities were obtained from the image analysis. Kd values were 
determined from the surface bound glycoconjugates G1–G6 as a function of lectin 
concentration [L] by the equation below. OriginPro 8 software was used to generate the 
equation for nonlinear curve-fitting of each glycoconjugate and plotted binding curves. 
4.4 Conclusion 
I have successfully developed a microarray with controlled carbohydrate 
presentations by immobilizing six synthetic α-linked glycoconjugates varied in linkage 
and size to an avidin-coated glass slide to imitate featured carbohydrate presentations. 
Quantitative evaluation of their binding properties toward fluorescence-labeled GSL I-B4 
lectin was achieved by directly fluorescence scanning and determination of Kd values. 
The lectin displayed stronger affinity with saccharides that possess the non-reducing 
terminal disaccharide Gal-α-(1,3)-Gal, disaccharide Gal-α-(1,4)-Gal and Gal-α-(1,6)-Gal. 
The insights gained will find applications in a wealth of biological recognition activities 
and more importantly, it will have broad implications for the construction of analytical 
platforms that display the complex arrangements of chemical epitopes commonly found 
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The fundamental role of oligosaccharides and glycoconjugates with 1,2-cis 
glycosidic linkages in biological activities of living systems has been discussed, and 
various strategies developed for the stereoselective construction of 1,2-cis-O-glycosidic 
bond has been thoroughly reviewed in Chapter 1. Although considerable achievements 
have been accomplished to access complex oligosaccharides, the development of general, 
efficient, and flexible approaches to achieve the intrinsic organizational diversity of 
carbohydrates is still urged in order to meet the substantial carbohydrates demand for 
biological, medicinal, and therapeutic studies. 
In this dissertation, a facile and general strategy for the direct construction of 1,2-
cis alkyl glycosides has been developed. Glycosylations between several unprotected 
phenyl 1-thioglycosyl donors and various functionalized alcohols were performed under 
the activation of NIS/TMSOTf. The reactions proceeded smoothly with satisfying yields 
and 1,2-cis-selectivity. The optimization of the glycosylation condition was carried out 
efficiently by an FIAESI-TOF-MS/
1
H NMR protocol, which enabled quantitative 
evaluation of reaction yield and stereoselectivity. The synthetic procedures described 
herein are anticipated to find application in the areas where 1,2-cis-linked glycosides is 
required.  
The development of synthetic glycoconjugate surfaces to imitate the natural 
carbohydrate landscape on the cell surface was also presented in order to facilitate the 
understanding of the structure–affinity relationships among carbohydrates in recognition 
with protein receptors. Six α-linked propargyl terminated galactosides with various 
spatial presentations were carefully designed for the construction of synthetic 




glycan ligands from different combinations of glycosylation donor and acceptors. The 
glycosyl acceptors were obtained via flexible and efficient regioselective protection 
strategies, and they were glycosylated with 4,6-di-tert-butylsilylene protected 
thiogalactoside donor to get the α-linked galactosides in exclusive stereoselective and 
satisfying yield. A monosaccharide, α-linked 1→2, 1→3, 1→4 and 1→6 disaccharides, 
and an α-linked galactose trisaccharide with propargyl terminus were synthesized and 
coupled with the azido-PEG-biotin linker by click chemistry. The prepared 
glycoconjugates were immobilized to an avidin-coated glass slide to afford the 
carbohydrate microarrays. A fluorescent-labeled lectin, DyLight 594-labeled GSL I-B4 
lectin, was employed with varied concentrations to determine the glycoarray recognitions 
and analyze their binding affinities and dissociation constants. The lectin showed stronger 
binding affinities with disaccharides that possess the non-reducing terminal Gal-α-(1,3)-
Gal, Gal-α-(1,4)-Gal and Gal-α-(1,6)-Gal aglycones. This study could add new 
dimensions to our understanding of the effects of carbohydrate ligands density, avidity, 



























gHSQC NMR and gHMBC 




































































































































































































































































































































































































































































































































































































































































C NMR Propargyl 2,3,4-tri-O-benzoyl-6-O-(2,3-di-O-benzoyl-4,6-O-di-tert-butylsilanediyl-α-D-galactopyranosyl)-α-D-



























































gCOSY NMR Propargyl 2,3,4-tri-O-acetyl-6-O-(2,3,4-tri-O-acetyl-6-O-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside)-α-D-
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